Paolo Fusar-Poli, M.D. Ph.D. - Publications

Affiliations: 
Institute of Psychiatry at the Maudsley King's College London, London, UK 
Area:
First episode of psychosis, fMRI, MRI

395 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Zhu Y, Maikusa N, Radua J, Sämann PG, Fusar-Poli P, Agartz I, Andreassen OA, Bachman P, Baeza I, Chen X, Choi S, Corcoran CM, Ebdrup BH, Fortea A, Garani RR, et al. Using brain structural neuroimaging measures to predict psychosis onset for individuals at clinical high-risk. Molecular Psychiatry. PMID 38332374 DOI: 10.1038/s41380-024-02426-7  0.462
2024 Choi H, Kim JH, Yang HS, Kim JY, Cortese S, Smith L, Koyanagi A, Dragioti E, Radua J, Fusar-Poli P, Shin JI, Cheon KA, Solmi M. Pharmacological and non-pharmacological interventions for irritability in autism spectrum disorder: a systematic review and meta-analysis with the GRADE assessment. Molecular Autism. 15: 7. PMID 38263251 DOI: 10.1186/s13229-024-00585-6  0.444
2024 Davies C, Martins D, Dipasquale O, McCutcheon RA, De Micheli A, Ramella-Cravaro V, Provenzani U, Rutigliano G, Cappucciati M, Oliver D, Williams S, Zelaya F, Allen P, Murguia S, Taylor D, ... ... Fusar-Poli P, et al. Connectome dysfunction in patients at clinical high risk for psychosis and modulation by oxytocin. Molecular Psychiatry. PMID 38243074 DOI: 10.1038/s41380-024-02406-x  0.678
2024 Efthimiou O, Taipale H, Radua J, Schneider-Thoma J, Pinzón-Espinosa J, Ortuño M, Vinkers CH, Mittendorfer-Rutz E, Cardoner N, Tanskanen A, Fusar-Poli P, Cipriani A, Vieta E, Leucht S, Tiihonen J, et al. Efficacy and effectiveness of antipsychotics in schizophrenia: network meta-analyses combining evidence from randomised controlled trials and real-world data. The Lancet. Psychiatry. 11: 102-111. PMID 38215784 DOI: 10.1016/S2215-0366(23)00366-8  0.631
2024 Catalan A, McCutcheon RA, Aymerich C, Pedruzo B, Radua J, Rodríguez V, Salazar de Pablo G, Pacho M, Pérez JL, Solmi M, McGuire P, Giuliano AJ, Stone WS, Murray RM, Gonzalez-Torres MA, ... Fusar-Poli P, et al. The magnitude and variability of neurocognitive performance in first-episode psychosis: a systematic review and meta-analysis of longitudinal studies. Translational Psychiatry. 14: 15. PMID 38191534 DOI: 10.1038/s41398-023-02718-6  0.572
2023 Patel R, Brinn A, Irving J, Chaturvedi J, Gudiseva S, Correll CU, Fusar-Poli P, McGuire P. Oral and long-acting injectable antipsychotic discontinuation and relationship to side effects in people with first episode psychosis: a longitudinal analysis of electronic health record data. Therapeutic Advances in Psychopharmacology. 13: 20451253231211575. PMID 38107162 DOI: 10.1177/20451253231211575  0.357
2023 Solmi M, Cortese S, Vita G, De Prisco M, Radua J, Dragioti E, Köhler-Forsberg O, Madsen NM, Rohde C, Eudave L, Aymerich C, Pedruzo B, Rodriguez V, Rosson S, Sabé M, ... ... Fusar-Poli P, et al. An umbrella review of candidate predictors of response, remission, recovery, and relapse across mental disorders. Molecular Psychiatry. PMID 37957292 DOI: 10.1038/s41380-023-02298-3  0.516
2023 Martini J, Bröckel KL, Leopold K, Berndt C, Sauer C, Maicher B, Juckel G, Krüger-Özgürdal S, Fallgatter AJ, Lambert M, Bechdolf A, Reif A, Matura S, Biere S, Kittel-Schneider S, ... ... Fusar-Poli P, et al. Young people at risk for developing bipolar disorder: Two-year findings from the multicenter prospective, naturalistic Early-BipoLife study. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 78: 43-53. PMID 37913697 DOI: 10.1016/j.euroneuro.2023.10.001  0.314
2023 Lukito S, Fortea L, Groppi F, Wykret KZ, Tosi E, Oliva V, Damiani S, Radua J, Fusar-Poli P. Should perception of emotions be classified according to threat detection rather than emotional valence? An updated meta-analysis for a whole-brain atlas of emotional faces processing. Journal of Psychiatry & Neuroscience : Jpn. 48: E376-E389. PMID 37857413 DOI: 10.1503/jpn.230065  0.383
2023 Oliver D, Englund A, Chesney E, Chester L, Wilson J, Sovi S, Wigroth S, Hodsoll J, Strang J, Murray RM, Freeman TP, Fusar-Poli P, McGuire P. Cannabidiol does not attenuate acute delta-9-tetrahydrocannabinol-induced attentional bias in healthy volunteers: A randomised, double-blind, cross-over study. Addiction (Abingdon, England). PMID 37821096 DOI: 10.1111/add.16353  0.3
2023 Haas SS, Ge R, Agartz I, Amminger GP, Andreassen OA, Bachman P, Baeza I, Choi S, Colibazzi T, Cropley VL, de la Fuente-Sandoval C, Ebdrup BH, Fortea A, Fusar-Poli P, Glenthøj BY, et al. Normative Modeling of Brain Morphometry in Clinical High Risk for Psychosis. Jama Psychiatry. PMID 37819650 DOI: 10.1001/jamapsychiatry.2023.3850  0.47
2023 Uher R, Pavlova B, Radua J, Provenzani U, Najafi S, Fortea L, Ortuño M, Nazarova A, Perroud N, Palaniyappan L, Domschke K, Cortese S, Arnold PD, Austin JC, Vanyukov MM, ... ... Fusar-Poli P, et al. Transdiagnostic risk of mental disorders in offspring of affected parents: a meta-analysis of family high-risk and registry studies. World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 22: 433-448. PMID 37713573 DOI: 10.1002/wps.21147  0.511
2023 Solmi M, De Toffol M, Kim JY, Choi MJ, Stubbs B, Thompson T, Firth J, Miola A, Croatto G, Baggio F, Michelon S, Ballan L, Gerdle B, Monaco F, Simonato P, ... ... Fusar-Poli P, et al. Balancing risks and benefits of cannabis use: umbrella review of meta-analyses of randomised controlled trials and observational studies. Bmj (Clinical Research Ed.). 382: e072348. PMID 37648266 DOI: 10.1136/bmj-2022-072348  0.474
2023 Livingston NR, De Micheli A, McCutcheon R, Butler E, Hamdan M, Grace AA, McGuire P, Egerton A, Fusar-Poli P, Modinos G. Effects of Benzodiazepine Exposure on Real-World Clinical Outcomes in Individuals at Clinical High-Risk for Psychosis. Medrxiv : the Preprint Server For Health Sciences. PMID 37645948 DOI: 10.1101/2023.08.15.23294108  0.424
2023 Minichino A, Preston T, Fanshawe JB, Fusar-Poli P, McGuire P, Burnet PW, Lennox BR. Psycho-pharmacomicrobiomics: a systematic review and meta-analysis. Biological Psychiatry. PMID 37567335 DOI: 10.1016/j.biopsych.2023.07.019  0.324
2023 Kim H, Kim JH, Kim J, Kim JY, Cortese S, Smith L, Koyanagi A, Radua J, Fusar-Poli P, Carvalho AF, Salazar de Pablo G, Shin JI, Cheon KA, Solmi M. Subjective and objective sleep alterations in medication-naïve children and adolescents with autism spectrum disorder: a systematic review and meta-analysis. Epidemiology and Psychiatric Sciences. 32: e48. PMID 37469173 DOI: 10.1017/S2045796023000574  0.411
2023 Pedruzo B, Aymerich C, Pacho M, Herrero J, Laborda M, Bordenave M, Giuliano AJ, McCutcheon RA, Gutiérrez-Rojas L, McGuire P, Stone WS, Fusar-Poli P, González-Torres MÁ, Catalan A. Longitudinal change in neurocognitive functioning in children and adolescents at clinical high risk for psychosis: a systematic review. European Child & Adolescent Psychiatry. PMID 37199754 DOI: 10.1007/s00787-023-02221-9  0.413
2023 Oliver D, Davies C, Zelaya F, Selvaggi P, De Micheli A, Catalan A, Baldwin H, Arribas M, Modinos G, Crossley NA, Allen P, Egerton A, Jauhar S, Howes OD, McGuire P, ... Fusar-Poli P, et al. Parsing neurobiological heterogeneity of the clinical high-risk state for psychosis: A pseudo-continuous arterial spin labelling study. Frontiers in Psychiatry. 14: 1092213. PMID 36970257 DOI: 10.3389/fpsyt.2023.1092213  0.748
2023 Cullen AE, Labad J, Oliver D, Al-Diwani A, Minichino A, Fusar-Poli P. The Translational Future of Stress Neurobiology and Psychosis Vulnerability: A Review of the Evidence. Current Neuropharmacology. PMID 36946486 DOI: 10.2174/1570159X21666230322145049  0.301
2023 De Micheli A, Provenzani U, Solmi M, Van Pabst AVL, Youssef E, McGuire P, Fusar-Poli P. Prevalence of tobacco smoking in people at clinical high-risk for psychosis: Systematic review and meta-analysis. Schizophrenia Research. 254: 109-115. PMID 36827942 DOI: 10.1016/j.schres.2023.02.008  0.371
2023 Gosling CJ, Solanes A, Fusar-Poli P, Radua J. metaumbrella: the first comprehensive suite to perform data analysis in umbrella reviews with stratification of the evidence. Bmj Mental Health. 26. PMID 36792173 DOI: 10.1136/bmjment-2022-300534  0.416
2023 Haas SS, Ge R, Agartz I, Amminger GP, Andreassen OA, Bachman P, Baeza I, Choi S, Colibazzi T, Cropley VL, de la Fuente-Sandoval C, Ebdrup BH, Fortea A, Fusar-Poli P, Glenthøj BY, et al. Normative modeling of brain morphometry in Clinical High-Risk for Psychosis. Biorxiv : the Preprint Server For Biology. PMID 36711551 DOI: 10.1101/2023.01.17.523348  0.471
2023 Estradé A, Spencer TJ, De Micheli A, Murguia-Asensio S, Provenzani U, McGuire P, Fusar-Poli P. Mapping the implementation and challenges of clinical services for psychosis prevention in England. Frontiers in Psychiatry. 13: 945505. PMID 36660464 DOI: 10.3389/fpsyt.2022.945505  0.403
2023 Dragioti E, Radua J, Solmi M, Gosling CJ, Oliver D, Lascialfari F, Ahmed M, Cortese S, Estradé A, Arrondo G, Gouva M, Fornaro M, Batiridou A, Dimou K, Tsartsalis D, ... ... Fusar-Poli P, et al. Impact of mental disorders on clinical outcomes of physical diseases: an umbrella review assessing population attributable fraction and generalized impact fraction. World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 22: 86-104. PMID 36640414 DOI: 10.1002/wps.21068  0.496
2022 Solmi M, Thompson T, Estradé A, Agorastos A, Radua J, Cortese S, Dragioti E, Leisch F, Vancampfort D, Thygesen LC, Aschauer H, Schloegelhofer M, Aschauer E, Schneeberger A, Huber CG, ... ... Fusar-Poli P, et al. Validation of the collaborative outcomes study on health and functioning during infection times (COH-FIT) questionnaire for adults. Journal of Affective Disorders. PMID 36586617 DOI: 10.1016/j.jad.2022.12.022  0.405
2022 Englund A, Oliver D, Chesney E, Chester L, Wilson J, Sovi S, De Micheli A, Hodsoll J, Fusar-Poli P, Strang J, Murray RM, Freeman TP, McGuire P. Does cannabidiol make cannabis safer? A randomised, double-blind, cross-over trial of cannabis with four different CBD:THC ratios. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 36380220 DOI: 10.1038/s41386-022-01478-z  0.369
2022 Baldwin H, Radua J, Antoniades M, Haas SS, Frangou S, Agartz I, Allen P, Andreassen OA, Atkinson K, Bachman P, Baeza I, Bartholomeusz CF, Chee MWL, Colibazzi T, Cooper RE, ... ... Fusar-Poli P, et al. Neuroanatomical heterogeneity and homogeneity in individuals at clinical high risk for psychosis. Translational Psychiatry. 12: 297. PMID 35882855 DOI: 10.1038/s41398-022-02057-y  0.574
2022 Monego E, Cremonese C, Gentili F, Fusar-Poli P, Shah JL, Solmi M. Clinical high at-risk mental state in young subjects accessing a mental disorder prevention service in Italy. Psychiatry Research. 316: 114710. PMID 35878479 DOI: 10.1016/j.psychres.2022.114710  0.31
2022 Kim JH, Kim JY, Lee S, Lee S, Stubbs B, Koyanagi A, Dragioti E, Jacob L, Carvalho AF, Radua J, Thompson T, Smith L, Oh H, Yang L, Fornaro M, ... ... Fusar-Poli P, et al. Environmental Risk Factors, Protective Factors, and Biomarkers for Postpartum Depressive Symptoms: An Umbrella Review. Neuroscience and Biobehavioral Reviews. 104761. PMID 35803397 DOI: 10.1016/j.neubiorev.2022.104761  0.472
2022 Solmi M, Song M, Yon DK, Lee SW, Fombonne E, Kim MS, Park S, Lee MH, Hwang J, Keller R, Koyanagi A, Jacob L, Dragioti E, Smith L, Correll CU, ... Fusar-Poli P, et al. Incidence, prevalence, and global burden of autism spectrum disorder from 1990 to 2019 across 204 countries. Molecular Psychiatry. PMID 35768640 DOI: 10.1038/s41380-022-01630-7  0.453
2022 Oliver D, Arribas M, Radua J, Salazar de Pablo G, De Micheli A, Spada G, Mensi MM, Kotlicka-Antczak M, Borgatti R, Solmi M, Shin JI, Woods SW, Addington J, McGuire P, Fusar-Poli P. Prognostic accuracy and clinical utility of psychometric instruments for individuals at clinical high-risk of psychosis: a systematic review and meta-analysis. Molecular Psychiatry. PMID 35665763 DOI: 10.1038/s41380-022-01611-w  0.601
2022 Catalan A, Radua J, McCutcheon R, Aymerich C, Pedruzo B, González-Torres MÁ, Baldwin H, Stone WS, Giuliano AJ, McGuire P, Fusar-Poli P. Examining the variability of neurocognitive functioning in individuals at clinical high risk for psychosis: a meta-analysis. Translational Psychiatry. 12: 198. PMID 35551176 DOI: 10.1038/s41398-022-01961-7  0.597
2022 Patel R, Irving J, Brinn A, Taylor M, Shetty H, Pritchard M, Stewart R, Fusar-Poli P, McGuire P. Associations of presenting symptoms and subsequent adverse clinical outcomes in people with unipolar depression: a prospective natural language processing (NLP), transdiagnostic, network analysis of electronic health record (EHR) data. Bmj Open. 12: e056541. PMID 35487729 DOI: 10.1136/bmjopen-2021-056541  0.343
2022 Dragioti E, Radua J, Solmi M, Arango C, Oliver D, Cortese S, Jones PB, Il Shin J, Correll CU, Fusar-Poli P. Global population attributable fraction of potentially modifiable risk factors for mental disorders: a meta-umbrella systematic review. Molecular Psychiatry. PMID 35484237 DOI: 10.1038/s41380-022-01586-8  0.536
2022 Catalan A, Aymerich C, Bilbao A, Pedruzo B, Pérez JL, Aranguren N, de Pablo GS, Hedges E, Gil P, Segarra R, González-Pinto A, Fernández-Rivas A, Inchausti L, McGuire P, Fusar-Poli P, et al. Psychosis and Substance Abuse increase the COVID-19 mortality risk. Psychological Medicine. 1-23. PMID 35410632 DOI: 10.1017/S0033291722000976  0.39
2022 Yoon S, Kim SE, Ko Y, Jeong GH, Lee KH, Lee J, Solmi M, Jacob L, Smith L, Stickley A, Carvalho AF, Dragioti E, Kronbichler A, Koyanagi A, Hong SH, ... ... Fusar-Poli P, et al. Correction: Differential expression of MicroRNAs in Alzheimer's disease: a systematic review and meta-analysis. Molecular Psychiatry. PMID 35393559 DOI: 10.1038/s41380-022-01534-6  0.383
2022 Kerins S, Nottage J, Salazar de Pablo G, Kempton MJ, Tognin S, Niemann DH, de Haan L, van Amelsvoort T, Kwon JS, Nelson B, Mizrahi R, McGuire P, Fusar-Poli P. Identifying Electroencephalography Biomarkers in Individuals at Clinical High Risk for Psychosis in an International Multi-Site Study. Frontiers in Psychiatry. 13: 828376. PMID 35370849 DOI: 10.3389/fpsyt.2022.828376  0.437
2022 Jauhar S, Laws K, Fusar-Poli P, McKenna P. Relapse prevention in schizophrenia. The Lancet. Psychiatry. 9: e13. PMID 35305747 DOI: 10.1016/S2215-0366(21)00501-0  0.439
2022 Yoon S, Kim SE, Ko Y, Jeong GH, Lee KH, Lee J, Solmi M, Jacob L, Smith L, Stickley A, Carvalho AF, Dragioti E, Kronbichler A, Koyanagi A, Hong SH, ... ... Fusar-Poli P, et al. Differential expression of MicroRNAs in Alzheimer's disease: a systematic review and meta-analysis. Molecular Psychiatry. PMID 35264731 DOI: 10.1038/s41380-022-01476-z  0.387
2022 Luna LP, Radua J, Fortea L, Sugranyes G, Fortea A, Fusar-Poli P, Smith L, Firth J, Shin JI, Brunoni AR, Husain MI, Husian MO, Sair HI, Mendes WO, Uchoa LRA, et al. A systematic review and meta-analysis of structural and functional brain alterations in individuals with genetic and clinical high-risk for psychosis and bipolar disorder. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 110540. PMID 35240226 DOI: 10.1016/j.pnpbp.2022.110540  0.546
2022 Fortea L, Albajes-Eizagirre A, Yao YW, Soler E, Verdolini N, Hauson AO, Fortea A, Madero S, Solanes A, Wollman SC, Serra-Blasco M, Wise T, Lukito S, Picó-Pérez M, Carlisi C, ... ... Fusar-Poli P, et al. Focusing on Comorbidity-A Novel Meta-Analytic Approach and Protocol to Disentangle the Specific Neuroanatomy of Co-occurring Mental Disorders. Frontiers in Psychiatry. 12: 807839. PMID 35115973 DOI: 10.3389/fpsyt.2021.807839  0.681
2022 Taipale H, Schneider-Thoma J, Pinzón-Espinosa J, Radua J, Efthimiou O, Vinkers CH, Mittendorfer-Rutz E, Cardoner N, Pintor L, Tanskanen A, Tomlinson A, Fusar-Poli P, Cipriani A, Vieta E, Leucht S, et al. Representation and Outcomes of Individuals With Schizophrenia Seen in Everyday Practice Who Are Ineligible for Randomized Clinical Trials. Jama Psychiatry. PMID 35080618 DOI: 10.1001/jamapsychiatry.2021.3990  0.641
2022 Salazar de Pablo G, Soardo L, Cabras A, Pereira J, Kaur S, Besana F, Arienti V, Coronelli F, Shin JI, Solmi M, Petros N, Carvalho AF, McGuire P, Fusar-Poli P. Clinical outcomes in individuals at clinical high risk of psychosis who do not transition to psychosis: a meta-analysis. Epidemiology and Psychiatric Sciences. 31: e9. PMID 35042573 DOI: 10.1017/S2045796021000639  0.446
2021 Solmi M, Estradé A, Thompson T, Agorastos A, Radua J, Cortese S, Dragioti E, Leisch F, Vancampfort D, Thygesen LC, Aschauer H, Schloegelhofer M, Akimova E, Schneeberger A, Huber CG, ... ... Fusar-Poli P, et al. The collaborative outcomes study on health and functioning during infection times in adults (COH-FIT-Adults): Design and methods of an international online survey targeting physical and mental health effects of the COVID-19 pandemic. Journal of Affective Disorders. 299: 393-407. PMID 34949568 DOI: 10.1016/j.jad.2021.07.048  0.406
2021 Kim JY, Choi MJ, Ha S, Hwang J, Koyanagi A, Dragioti E, Radua J, Smith L, Jacob L, de Pablo GS, Lee SW, Yon DK, Thompson T, Cortese S, Lollo G, ... ... Fusar-Poli P, et al. Association between autism spectrum disorder and inflammatory bowel disease: A systematic review and meta-analysis. Autism Research : Official Journal of the International Society For Autism Research. PMID 34939353 DOI: 10.1002/aur.2656  0.455
2021 Morgan SE, Diederen K, Vértes PE, Ip SHY, Wang B, Thompson B, Demjaha A, De Micheli A, Oliver D, Liakata M, Fusar-Poli P, Spencer TJ, McGuire P. Natural Language Processing markers in first episode psychosis and people at clinical high-risk. Translational Psychiatry. 11: 630. PMID 34903724 DOI: 10.1038/s41398-021-01722-y  0.375
2021 Fusar-Poli P, Radua J, Davies C, Jauhar S. Overoptimistic Literature and Methodological Biases Favoring Cognitive Behavioral Therapy for the Prevention of Psychosis. Schizophrenia Bulletin. PMID 34757422 DOI: 10.1093/schbul/sbab129  0.691
2021 Lee S, Lee KH, Park KM, Park SJ, Kim WJ, Lee J, Kronbichler A, Smith L, Solmi M, Stubbs B, Koyanagi A, Jacob L, Stickley A, Thompson T, Dragioti E, ... ... Fusar-Poli P, et al. Impact of data extraction errors in meta-analyses on the association between depression and peripheral inflammatory biomarkers: an umbrella review. Psychological Medicine. 1-14. PMID 34749836 DOI: 10.1017/S0033291721003767  0.393
2021 Catalan A, Richter A, Salazar de Pablo G, Vaquerizo-Serrano J, Mancebo G, Pedruzo B, Aymerich C, Solmi M, González-Torres MÁ, Gil P, McGuire P, Fusar-Poli P. Proportion and predictors of remission and recovery in first-episode psychosis: Systematic review and meta-analysis. European Psychiatry : the Journal of the Association of European Psychiatrists. 64: e69. PMID 34730080 DOI: 10.1192/j.eurpsy.2021.2246  0.378
2021 Solmi M, Estradé A, Thompson T, Agorastos A, Radua J, Cortese S, Dragioti E, Leisch F, Vancampfort D, Thygesen LC, Aschauer H, Schloegelhofer M, Akimova E, Schneeberger A, Huber CG, ... ... Fusar-Poli P, et al. Physical and mental health impact of COVID-19 on children, adolescents, and their families: The Collaborative Outcomes study on Health and Functioning during Infection Times - Children and Adolescents (COH-FIT-C&A). Journal of Affective Disorders. 299: 367-376. PMID 34606810 DOI: 10.1016/j.jad.2021.09.090  0.392
2021 Solmi M, Dragioti E, Croatto G, Radua J, Borgwardt S, Carvalho AF, Demurtas J, Mosina A, Kurotschka P, Thompson T, Cortese S, Shin JI, Fusar-Poli P. Risk and Protective Factors for Personality Disorders: An Umbrella Review of Published Meta-Analyses of Case-Control and Cohort Studies. Frontiers in Psychiatry. 12: 679379. PMID 34552513 DOI: 10.3389/fpsyt.2021.679379  0.502
2021 Fusar-Poli P, Radua J, Jauhar S. Lack of robust meta-analytic evidence to favour cognitive behavioural therapy for prevention of psychosis. World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 20: 443-444. PMID 34505393 DOI: 10.1002/wps.20896  0.422
2021 Koutsouleris N, Worthington M, Dwyer DB, Kambeitz-Ilankovic L, Sanfelici R, Fusar-Poli P, Rosen M, Ruhrmann S, Anticevic A, Addington J, Perkins DO, Bearden CE, Cornblatt BA, Cadenhead KS, Mathalon DH, et al. Toward Generalizable and Transdiagnostic Tools for Psychosis Prediction: An Independent Validation and Improvement of the NAPLS-2 Risk Calculator in the Multisite PRONIA Cohort. Biological Psychiatry. PMID 34482951 DOI: 10.1016/j.biopsych.2021.06.023  0.471
2021 Schirmbeck F, van der Burg NC, Blankers M, Vermeulen JM, McGuire P, Valmaggia LR, Kempton MJ, van der Gaag M, Riecher-Rössler A, Bressan RA, Barrantes-Vidal N, Nelson B, Amminger GP, McGorry P, Pantelis C, ... ... Fusar-Poli P, et al. Impact of Comorbid Affective Disorders on Longitudinal Clinical Outcomes in Individuals at Ultra-high Risk for Psychosis. Schizophrenia Bulletin. PMID 34417795 DOI: 10.1093/schbul/sbab088  0.471
2021 Salazar de Pablo G, Solmi M, Vaquerizo-Serrano J, Radua J, Passina A, Morsillo P, Correll CU, Borgwardt S, Galderisi S, Bechdolf A, Pfennig A, Bauer M, Kessing LV, van Amelsvoort T, Nieman DH, ... ... Fusar-Poli P, et al. Primary prevention of depression: An umbrella review of controlled interventions. Journal of Affective Disorders. 294: 957-970. PMID 34375224 DOI: 10.1016/j.jad.2021.07.101  0.5
2021 de Pablo GS, Davies C, de Diego H, Solmi M, Shin JI, Carvalho AF, Radua J, Fusar-Poli P. Transition to psychosis in randomised clinical trials of individuals at clinical high risk of psychosis compared to observational cohorts: a systematic review and meta-analysis. European Psychiatry : the Journal of the Association of European Psychiatrists. 1-22. PMID 34315555 DOI: 10.1192/j.eurpsy.2021.2222  0.751
2021 Salazar de Pablo G, Radua J, Pereira J, Bonoldi I, Arienti V, Besana F, Soardo L, Cabras A, Fortea L, Catalan A, Vaquerizo-Serrano J, Coronelli F, Kaur S, Da Silva J, Shin JI, ... ... Fusar-Poli P, et al. Probability of Transition to Psychosis in Individuals at Clinical High Risk: An Updated Meta-analysis. Jama Psychiatry. PMID 34259821 DOI: 10.1001/jamapsychiatry.2021.0830  0.599
2021 Salazar de Pablo G, Besana F, Arienti V, Catalan A, Vaquerizo-Serrano J, Cabras A, Pereira J, Soardo L, Coronelli F, Kaur S, da Silva J, Oliver D, Petros N, Moreno C, Gonzalez-Pinto A, ... ... Fusar-Poli P, et al. Longitudinal outcome of attenuated positive symptoms, negative symptoms, functioning and remission in people at clinical high risk for psychosis: a meta-analysis. Eclinicalmedicine. 36: 100909. PMID 34189444 DOI: 10.1016/j.eclinm.2021.100909  0.456
2021 Catalan A, Salazar de Pablo G, Aymerich C, Damiani S, Sordi V, Radua J, Oliver D, McGuire P, Giuliano AJ, Stone WS, Fusar-Poli P. Neurocognitive Functioning in Individuals at Clinical High Risk for Psychosis: A Systematic Review and Meta-analysis. Jama Psychiatry. PMID 34132736 DOI: 10.1001/jamapsychiatry.2021.1290  0.611
2021 Solmi M, Radua J, Olivola M, Croce E, Soardo L, Salazar de Pablo G, Il Shin J, Kirkbride JB, Jones P, Kim JH, Kim JY, Carvalho AF, Seeman MV, Correll CU, Fusar-Poli P. Age at onset of mental disorders worldwide: large-scale meta-analysis of 192 epidemiological studies. Molecular Psychiatry. PMID 34079068 DOI: 10.1038/s41380-021-01161-7  0.467
2021 Fortea A, Batalla A, Radua J, van Eijndhoven P, Baeza I, Albajes-Eizagirre A, Fusar-Poli P, Castro-Fornieles J, De la Serna E, Luna LP, Carvalho AF, Vieta E, Sugranyes G. Cortical gray matter reduction precedes transition to psychosis in individuals at clinical high-risk for psychosis: A voxel-based meta-analysis. Schizophrenia Research. 232: 98-106. PMID 34029948 DOI: 10.1016/j.schres.2021.05.008  0.547
2021 Salazar de Pablo G, De Micheli A, Solmi M, Oliver D, Catalan A, Verdino V, Di Maggio L, Bonoldi I, Radua J, Baccaredda Boy O, Provenzani U, Ruzzi F, Calorio F, Nosari G, Di Marco B, ... ... Fusar-Poli P, et al. Universal and Selective Interventions to Prevent Poor Mental Health Outcomes in Young People: Systematic Review and Meta-analysis. Harvard Review of Psychiatry. 29: 196-215. PMID 33979106 DOI: 10.1097/HRP.0000000000000294  0.482
2021 Jalbrzikowski M, Hayes RA, Wood SJ, Nordholm D, Zhou JH, Fusar-Poli P, Uhlhaas PJ, Takahashi T, Sugranyes G, Kwak YB, Mathalon DH, Katagiri N, Hooker CI, Smigielski L, et al. Association of Structural Magnetic Resonance Imaging Measures With Psychosis Onset in Individuals at Clinical High Risk for Developing Psychosis: An ENIGMA Working Group Mega-analysis. Jama Psychiatry. PMID 33950164 DOI: 10.1001/jamapsychiatry.2021.0638  0.47
2021 Irving J, Colling C, Shetty H, Pritchard M, Stewart R, Fusar-Poli P, McGuire P, Patel R. Gender differences in clinical presentation and illicit substance use during first episode psychosis: a natural language processing, electronic case register study. Bmj Open. 11: e042949. PMID 33879482 DOI: 10.1136/bmjopen-2020-042949  0.338
2021 Solmi M, Dragioti E, Croatto G, Radua J, Borgwardt S, Carvalho AF, Demurtas J, Mosina A, Kurotschka PK, Shin JI, Fusar-Poli P. Risk and protective factors for cannabis, cocaine, and opioid use disorders: an umbrella review of meta-analyses of observational studies. Neuroscience and Biobehavioral Reviews. PMID 33737104 DOI: 10.1016/j.neubiorev.2021.03.014  0.48
2021 Fusar-Poli P, De Micheli A, Signorini L, Baldwin H, Salazar de Pablo G, McGuire P. Corrigendum to "Real-world long-term outcomes in individuals at clinical risk for psychosis: The case for extending duration of care" [EClinicalMedicine 28 (2020) 100,578]. Eclinicalmedicine. 32: 100729. PMID 33598646 DOI: 10.1016/j.eclinm.2021.100729  0.39
2021 Moore TM, Calkins ME, Rosen AFG, Butler ER, Ruparel K, Fusar-Poli P, Koutsouleris N, McGuire P, Cannon TD, Gur RC, Gur RE. Development of a probability calculator for psychosis risk in children, adolescents, and young adults. Psychological Medicine. 1-9. PMID 33431073 DOI: 10.1017/S0033291720005231  0.426
2020 Fusar-Poli P, Lai S, Di Forti M, Iacoponi E, Thornicroft G, McGuire P, Jauhar S. Early Intervention Services for First Episode of Psychosis in South London and the Maudsley (SLaM): 20 Years of Care and Research for Young People. Frontiers in Psychiatry. 11: 577110. PMID 33329115 DOI: 10.3389/fpsyt.2020.577110  0.345
2020 Fusar-Poli P, De Micheli A, Signorini L, Baldwin H, de Pablo GS, McGuire P. Real-world long-term outcomes in individuals at clinical risk for psychosis: The case for extending duration of care. Eclinicalmedicine. 28: 100578. PMID 33294806 DOI: 10.1016/j.eclinm.2020.100578  0.413
2020 Solmi M, Civardi S, Corti R, John A, Demurtas J, Lange S, Radua J, Dragioti E, Fusar-Poli P, Carvalho AF. Risk and protective factors for alcohol and tobacco related disorders: an umbrella review of observational studies. Neuroscience and Biobehavioral Reviews. PMID 33248149 DOI: 10.1016/j.neubiorev.2020.11.010  0.513
2020 Fusar-Poli P, Oliver D, Spada G, Estrade A, McGuire P. The case for improved transdiagnostic detection of first-episode psychosis: Electronic health record cohort study. Schizophrenia Research. PMID 33234425 DOI: 10.1016/j.schres.2020.11.031  0.366
2020 Solanes A, Albajes-Eizagirre A, Fullana MA, Fortea L, Fusar-Poli P, Torrent C, Solé B, Bonnín CM, Shin JI, Vieta E, Radua J. Can we increase the subjective well-being of the general population? An umbrella review of the evidence. Revista De Psiquiatria Y Salud Mental. PMID 33160879 DOI: 10.1016/j.rpsm.2020.08.002  0.442
2020 Oliver D, Wong CMJ, Bøg M, Jönsson L, Kinon BJ, Wehnert A, Jørgensen KT, Irving J, Stahl D, McGuire P, Raket LL, Fusar-Poli P. Transdiagnostic individualized clinically-based risk calculator for the automatic detection of individuals at-risk and the prediction of psychosis: external replication in 2,430,333 US patients. Translational Psychiatry. 10: 364. PMID 33122625 DOI: 10.1038/s41398-020-01032-9  0.474
2020 Kim JH, Kim JY, Lee J, Jeong GH, Lee E, Lee S, Lee KH, Kronbichler A, Stubbs B, Solmi M, Koyanagi A, Hong SH, Dragioti E, Jacob L, Brunoni AR, ... ... Fusar-Poli P, et al. Environmental risk factors, protective factors, and peripheral biomarkers for ADHD: an umbrella review. The Lancet. Psychiatry. 7: 955-970. PMID 33069318 DOI: 10.1016/S2215-0366(20)30312-6  0.45
2020 Lee J, Son MJ, Son CY, Jeong GH, Lee KH, Lee KS, Ko Y, Kim JY, Lee JY, Radua J, Eisenhut M, Gressier F, Koyanagi A, Stubbs B, Solmi M, ... ... Fusar-Poli P, et al. Genetic Variation and Autism: A Field Synopsis and Systematic Meta-Analysis. Brain Sciences. 10. PMID 33007889 DOI: 10.3390/brainsci10100692  0.473
2020 Solmi M, Radua J, Stubbs B, Ricca V, Moretti D, Busatta D, Carvalho AF, Dragioti E, Favaro A, Monteleone AM, Shin JI, Fusar-Poli P, Castellini G. Risk factors for eating disorders: an umbrella review of published meta-analyses. Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999). PMID 32997075 DOI: 10.1590/1516-4446-2020-1099  0.492
2020 Spencer TJ, Thompson B, Oliver D, Diederen K, Demjaha A, Weinstein S, Morgan SE, Day F, Valmaggia L, Rutigliano G, De Micheli A, Mota NB, Fusar-Poli P, McGuire P. Lower speech connectedness linked to incidence of psychosis in people at clinical high risk. Schizophrenia Research. PMID 32951966 DOI: 10.1016/J.Schres.2020.09.002  0.516
2020 Marco S, Dragioti E, Arango C, Radua J, Ostinelli E, Kilic O, Yilmaz UE, Yalcinay-İnan M, Soares FC, Mariano L, Mosillo P, Cortese S, Correll CU, Carvalho AF, Shin JI, ... Fusar-Poli P, et al. Risk and protective factors for mental disorders with onset in childhood/adolescence: an umbrella review of published meta-analyses of observational longitudinal studies. Neuroscience and Biobehavioral Reviews. PMID 32931804 DOI: 10.1016/J.Neubiorev.2020.09.002  0.552
2020 Fusar-Poli P, Spencer T, De Micheli A, Curzi V, Nandha S, McGuire P. Outreach and support in South-London (OASIS) 2001-2020: Twenty years of early detection, prognosis and preventive care for young people at risk of psychosis. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 32921544 DOI: 10.1016/J.Euroneuro.2020.08.002  0.523
2020 Salazar de Pablo G, Studerus E, Vaquerizo-Serrano J, Irving J, Catalan A, Oliver D, Baldwin H, Danese A, Fazel S, Steyerberg EW, Stahl D, Fusar-Poli P. Implementing Precision Psychiatry: A Systematic Review of Individualized Prediction Models for Clinical Practice. Schizophrenia Bulletin. PMID 32914178 DOI: 10.1093/Schbul/Sbaa120  0.364
2020 Cortese S, Solmi M, Arrondo G, Cipriani A, Fusar-Poli P, Larsson H, Correll C. Association between mental disorders and somatic conditions: protocol for an umbrella review. Evidence-Based Mental Health. PMID 32900790 DOI: 10.1136/Ebmental-2020-300158  0.315
2020 Fusar-Poli P, Radua J, McKenna PJ, Laws K, Davies C, Jauhar S. Methodological Biases in CBT Trial-Commentary: Modular Cognitive-Behavioral Therapy for Affective Symptoms in Young Individuals at Ultra-High Risk of First Episode of Psychosis: Randomized Controlled Trial. Frontiers in Psychiatry. 11: 394. PMID 32848896 DOI: 10.3389/Fpsyt.2020.00394  0.781
2020 Petros N, Cullen AE, Fusar-Poli P, Mechelli A, McGuire P. Towards standardising the assessment of good outcome in people at clinical high risk for psychosis: A collaborative approach. Schizophrenia Research. PMID 32713747 DOI: 10.1016/J.Schres.2020.07.006  0.506
2020 Rogers JP, Chesney E, Oliver D, Pollak TA, McGuire P, Fusar-Poli P, Zandi MS, Lewis G, David AS. Psychiatric and neuropsychiatric syndromes and COVID-19 - Authors' reply. The Lancet. Psychiatry. 7: 664-665. PMID 32711701 DOI: 10.1016/S2215-0366(20)30304-7  0.404
2020 Martins D, Davies C, De Micheli A, Oliver D, Krawczun-Rygmaczewska A, Fusar-Poli P, Paloyelis Y. Intranasal oxytocin increases heart-rate variability in men at clinical high risk for psychosis: a proof-of-concept study. Translational Psychiatry. 10: 227. PMID 32655132 DOI: 10.1038/S41398-020-00890-7  0.706
2020 Schmidt A, Davies C, Paloyelis Y, Meyer N, De Micheli A, Ramella-Cravaro V, Provenzani U, Aoki Y, Rutigliano G, Cappucciati M, Oliver D, Murguia S, Zelaya F, Allen P, Shergill S, ... ... Fusar-Poli P, et al. Acute oxytocin effects in inferring others' beliefs and social emotions in people at clinical high risk for psychosis. Translational Psychiatry. 10: 203. PMID 32572020 DOI: 10.1038/S41398-020-00885-4  0.715
2020 Oliver D, Spada G, Colling C, Broadbent M, Baldwin H, Patel R, Stewart R, Stahl D, Dobson R, McGuire P, Fusar-Poli P. Real-world implementation of precision psychiatry: Transdiagnostic risk calculator for the automatic detection of individuals at-risk of psychosis. Schizophrenia Research. PMID 32571619 DOI: 10.1016/J.Schres.2020.05.007  0.499
2020 Wang T, Oliver D, Msosa Y, Colling C, Spada G, Roguski Ł, Folarin A, Stewart R, Roberts A, Dobson RJB, Fusar-Poli P. Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack. Journal of Visualized Experiments : Jove. PMID 32478737 DOI: 10.3791/60794  0.386
2020 Radua J, Davies C, Fusar-Poli P. Evaluation of variability in individual response to treatments in the clinical high-risk state for psychosis: A meta-analysis. Schizophrenia Research. PMID 32467067 DOI: 10.1016/J.Schres.2020.05.010  0.771
2020 Petros N, Cullen AE, Vieira S, Rowland E, King G, Leung WS, Fusar-Poli P, Mechelli A, McGuire P. Examining service-user perspectives for the development of a good outcome checklist for individuals at clinical high risk for psychosis. Early Intervention in Psychiatry. PMID 32453511 DOI: 10.1111/Eip.12991  0.432
2020 Rogers JP, Chesney E, Oliver D, Pollak TA, McGuire P, Fusar-Poli P, Zandi MS, Lewis G, David AS. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. The Lancet. Psychiatry. PMID 32437679 DOI: 10.1016/S2215-0366(20)30203-0  0.417
2020 Carvalho AF, Solmi M, Sanches M, Machado MO, Stubbs B, Ajnakina O, Sherman C, Sun YR, Liu CS, Brunoni AR, Pigato G, Fernandes BS, Bortolato B, Husain MI, Dragioti E, ... ... Fusar-Poli P, et al. Evidence-based umbrella review of 162 peripheral biomarkers for major mental disorders. Translational Psychiatry. 10: 152. PMID 32424116 DOI: 10.1038/S41398-020-0835-5  0.378
2020 Woods SW, Bearden CE, Sabb FW, Stone WS, Torous J, Cornblatt BA, Perkins DO, Cadenhead KS, Addington J, Powers AR, Mathalon DH, Calkins ME, Wolf DH, Corcoran CM, Horton LE, ... ... Fusar-Poli P, et al. Counterpoint. Early intervention for psychosis risk syndromes: Minimizing risk and maximizing benefit. Schizophrenia Research. PMID 32402605 DOI: 10.1016/J.Schres.2020.04.020  0.371
2020 Oliver D, Spada G, Englund A, Chesney E, Radua J, Reichenberg A, Uher R, McGuire P, Fusar-Poli P. Real-world digital implementation of the Psychosis Polyrisk Score (PPS): A pilot feasibility study. Schizophrenia Research. PMID 32340785 DOI: 10.1016/J.Schres.2020.04.015  0.636
2020 Fusar-Poli P, De Micheli A, Patel R, Signorini L, Miah S, Spencer T, McGuire P. Real-World Clinical Outcomes Two Years After Transition to Psychosis in Individuals at Clinical High Risk: Electronic Health Record Cohort Study. Schizophrenia Bulletin. PMID 32303767 DOI: 10.1093/Schbul/Sbaa040  0.516
2020 Minichino A, Brondino N, Solmi M, Del Giovane C, Fusar-Poli P, Burnet P, Cipriani A, Lennox BR. The gut-microbiome as a target for the treatment of schizophrenia: A systematic review and meta-analysis of randomised controlled trials of add-on strategies. Schizophrenia Research. PMID 32295752 DOI: 10.1016/J.Schres.2020.02.012  0.367
2020 Davies C, Segre G, Estradé A, Radua J, De Micheli A, Provenzani U, Oliver D, Salazar de Pablo G, Ramella-Cravaro V, Besozzi M, Dazzan P, Miele M, Caputo G, Spallarossa C, Crossland G, ... ... Fusar-Poli P, et al. Prenatal and perinatal risk and protective factors for psychosis: a systematic review and meta-analysis. The Lancet. Psychiatry. PMID 32220288 DOI: 10.1016/S2215-0366(20)30057-2  0.786
2020 Fusar-Poli P, Salazar de Pablo G, Correll CU, Meyer-Lindenberg A, Millan MJ, Borgwardt S, Galderisi S, Bechdolf A, Pfennig A, Kessing LV, van Amelsvoort T, Nieman DH, Domschke K, Krebs MO, Koutsouleris N, et al. Prevention of Psychosis: Advances in Detection, Prognosis, and Intervention. Jama Psychiatry. PMID 32159746 DOI: 10.1001/Jamapsychiatry.2019.4779  0.485
2020 De Micheli A, van Lawick van Pabst A, Yossef E, McGuire P, Fusar-Poli P. S154. TOBACCO SMOKING AND CLINICAL HIGH RISK: A SYSTEMATIC REVIEW AND META-ANALYSIS OF THE EVIDENCE Schizophrenia Bulletin. 46: S94-S95. DOI: 10.1093/Schbul/Sbaa031.220  0.515
2020 Oliver D, Spada G, Radua J, McGuire P, Fusar-Poli P. M136. PSYCHOSIS POLYRISK SCORE (PPS): IMPROVING DETECTION OF INDIVIDUALS AT-RISK AND PREDICTION OF CLINICAL OUTCOMES Schizophrenia Bulletin. 46: S187-S187. DOI: 10.1093/Schbul/Sbaa030.448  0.66
2020 Minichino A, Brondino N, Solmi M, Giovane CD, Correll CU, Fusar-poli P, Burnet P, Cipriani A, Lennox B. T175. The Gut-Microbiota As A Target For The Treatment Of Negative Symptoms Of Schizophrenia: A Systematic Review And Meta-Analysis Of Controlled Trials Of Add-On Strategies Schizophrenia Bulletin. 46. DOI: 10.1093/Schbul/Sbaa029.735  0.323
2020 Schmidt A, Davies C, Paloyelis Y, Rutigliano G, Cappucciati M, De Micheli A, Ramella-Cravaro V, Provenzani U, Scutt E, Oliver D, Murguia S, Zelaya F, Allen P, Shergill S, Morrison P, ... ... Fusar-poli P, et al. T139. OXYTOCIN ENHANCES NEURAL EFFICIENCY IN INFERRING OTHERS’ SOCIAL EMOTIONS IN PEOPLE AT CLINICAL HIGH RISK FOR PSYCHOSIS Schizophrenia Bulletin. 46: S283-S284. DOI: 10.1093/Schbul/Sbaa029.699  0.719
2020 Irving J, Colling C, Shetty H, Pritchard M, Stewart R, Fusar-Poli P, McGuire P, Patel R. T127. GENDER DIFFERENCES IN CLINICAL PRESENTATION AND ILLICIT SUBSTANCE USE DURING FIRST EPISODE PSYCHOSIS: AN ELECTRONIC CASE REGISTER NATURAL LANGUAGE PROCESSING ANALYSIS Schizophrenia Bulletin. 46: S278-S279. DOI: 10.1093/Schbul/Sbaa029.687  0.46
2020 Patel R, Irving J, Taylor M, Shetty H, Pritchard M, Stewart R, Fusar-Poli P, McGuire P. T109. TRAVERSING THE TRANSDIAGNOSTIC GAP BETWEEN DEPRESSION, MANIA AND PSYCHOSIS WITH NATURAL LANGUAGE PROCESSING Schizophrenia Bulletin. 46: S272-S273. DOI: 10.1093/Schbul/Sbaa029.669  0.485
2020 Oliver D, Spada G, Patel R, Stewart R, Dobson R, McGuire P, Fusar-Poli P. T97. REAL WORLD IMPLEMENTATION OF A TRANSDIAGNOSTIC RISK CALCULATOR FOR THE AUTOMATIC DETECTION OF INDIVIDUALS AT RISK OF PSYCHOSIS IN CLINICAL ROUTINE Schizophrenia Bulletin. 46: S268-S268. DOI: 10.1093/Schbul/Sbaa029.657  0.528
2019 Fusar-Poli P, Davies C, Solmi M, Brondino N, De Micheli A, Kotlicka-Antczak M, Shin JI, Radua J. Preventive Treatments for Psychosis: Umbrella Review (Just the Evidence). Frontiers in Psychiatry. 10: 764. PMID 31920732 DOI: 10.3389/Fpsyt.2019.00764  0.78
2019 Albajes-Eizagirre A, Solanes A, Fullana MA, Ioannidis JPA, Fusar-Poli P, Torrent C, Solé B, Bonnín CM, Vieta E, Mataix-Cols D, Radua J. Meta-analysis of Voxel-Based Neuroimaging Studies using Seed-based d Mapping with Permutation of Subject Images (SDM-PSI). Journal of Visualized Experiments : Jove. PMID 31840658 DOI: 10.3791/59841  0.616
2019 Tognin S, Grady L, Ventura S, Valmaggia L, Sear V, McGuire P, Fusar-Poli P, Spencer TJ. The Provision of Education and Employment Support At the Outreach and Support in South London (OASIS) Service for People at Clinical High Risk for Psychosis. Frontiers in Psychiatry. 10: 799. PMID 31780966 DOI: 10.3389/Fpsyt.2019.00799  0.493
2019 Salazar de Pablo G, Catalan A, Fusar-Poli P. Clinical Validity of DSM-5 Attenuated Psychosis Syndrome: Advances in Diagnosis, Prognosis, and Treatment. Jama Psychiatry. PMID 31746950 DOI: 10.1001/Jamapsychiatry.2019.3561  0.318
2019 Fusar-Poli P, De Micheli A, Chalambrides M, Singh A, Augusto C, McGuire P. Unmet needs for treatment in 102 individuals with brief and limited intermittent psychotic symptoms (BLIPS): implications for current clinical recommendations. Epidemiology and Psychiatric Sciences. 1-9. PMID 31739812 DOI: 10.1017/S2045796019000635  0.511
2019 Bhavsar V, Dorrington S, Morgan C, Hatch SL, McGuire P, Fusar-Poli P, Mills J, MacCabe JH, Hotopf M. Psychotic experiences, psychiatric comorbidity and mental health need in the general population: a cross-sectional and cohort study in Southeast London. Psychological Medicine. 1-11. PMID 31713511 DOI: 10.1017/S0033291719003106  0.462
2019 Fusar-Poli P, Sullivan SA, Shah JL, Uhlhaas PJ. Improving the Detection of Individuals at Clinical Risk for Psychosis in the Community, Primary and Secondary Care: An Integrated Evidence-Based Approach. Frontiers in Psychiatry. 10: 774. PMID 31708822 DOI: 10.3389/Fpsyt.2019.00774  0.411
2019 Fusar-Poli P, Estradé A, Spencer TJ, Gupta S, Murguia-Asensio S, Eranti S, Wilding K, Andlauer O, Buhagiar J, Smith M, Fitzell S, Sear V, Ademan A, De Micheli A, McGuire P. Pan-London Network for Psychosis-Prevention (PNP). Frontiers in Psychiatry. 10: 707. PMID 31681029 DOI: 10.3389/Fpsyt.2019.00707  0.454
2019 Fusar-Poli P. Specialized services for individuals at clinical high risk for psychosis target simultaneously adolescents and young adults. International Journal of Technology Assessment in Health Care. 1-2. PMID 31630701 DOI: 10.1017/S0266462319000692  0.32
2019 Fornaro M, Maritan E, Ferranti R, Zaninotto L, Miola A, Anastasia A, Murru A, Solé E, Stubbs B, Carvalho AF, Serretti A, Vieta E, Fusar-Poli P, McGuire P, Young AH, et al. Lithium Exposure During Pregnancy and the Postpartum Period: A Systematic Review and Meta-Analysis of Safety and Efficacy Outcomes. The American Journal of Psychiatry. appiajp201919030228. PMID 31623458 DOI: 10.1176/Appi.Ajp.2019.19030228  0.444
2019 Fusar-Poli P, Bauer M, Borgwardt S, Bechdolf A, Correll CU, Do KQ, Domschke K, Galderisi S, Kessing LV, Koutsouleris N, Krebs MO, Lennox B, McGuire P, Meyer-Lindenberg A, Millan MJ, et al. European college of neuropsychopharmacology network on the prevention of mental disorders and mental health promotion (ECNP PMD-MHP). European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 31606303 DOI: 10.1016/J.Euroneuro.2019.09.006  0.453
2019 Reilly T, Mechelli A, McGuire P, Fusar-Poli P, Uhlhaas PJ. E-Clinical High Risk for Psychosis: Viewpoint on Potential of Digital Innovations for Preventive Psychiatry. Jmir Mental Health. 6: e14581. PMID 31584006 DOI: 10.2196/14581  0.465
2019 Dragioti E, Solmi M, Favaro A, Fusar-Poli P, Dazzan P, Thompson T, Stubbs B, Firth J, Fornaro M, Tsartsalis D, Carvalho AF, Vieta E, McGuire P, Young AH, Shin JI, et al. Association of Antidepressant Use With Adverse Health Outcomes: A Systematic Umbrella Review. Jama Psychiatry. PMID 31577342 DOI: 10.1001/Jamapsychiatry.2019.2859  0.435
2019 Tortella-Feliu M, Fullana MA, Pérez-Vigil A, Torres X, Chamorro J, Littarelli SA, Solanes A, Ramella-Cravaro V, Vilar A, González-Parra JA, Andero R, Reichenberg PA, Mataix-Cols PD, Vieta E, Fusar-Poli P, et al. Risk factors for posttraumatic stress disorder: an umbrella review of systematic reviews and meta-analyses. Neuroscience and Biobehavioral Reviews. PMID 31520677 DOI: 10.1016/J.Neubiorev.2019.09.013  0.552
2019 Tognin S, van Hell HH, Merritt K, Winter-van Rossum I, Bossong MG, Kempton MJ, Modinos G, Fusar-Poli P, Mechelli A, Dazzan P, Maat A, De Haan L, Crespo-Facorro B, Glenthøj B, Lawrie SM, et al. Towards Precision Medicine in Psychosis: Benefits and Challenges of Multimodal Multicenter Studies-PSYSCAN: Translating Neuroimaging Findings From Research into Clinical Practice. Schizophrenia Bulletin. PMID 31424555 DOI: 10.1093/Schbul/Sbz067  0.473
2019 Studerus E, Beck K, Fusar-Poli P, Riecher-Rössler A. Development and Validation of a Dynamic Risk Prediction Model to Forecast Psychosis Onset in Patients at Clinical High Risk. Schizophrenia Bulletin. PMID 31355885 DOI: 10.1093/Schbul/Sbz059  0.35
2019 Fusar-Poli P. Integrated Mental Health Services for the Developmental Period (0 to 25 Years): A Critical Review of the Evidence. Frontiers in Psychiatry. 10: 355. PMID 31231250 DOI: 10.3389/Fpsyt.2019.00355  0.334
2019 Kim JY, Son MJ, Son CY, Radua J, Eisenhut M, Gressier F, Koyanagi A, Carvalho AF, Stubbs B, Solmi M, Rais TB, Lee KH, Kronbichler A, Dragioti E, Shin JI, ... Fusar-Poli P, et al. Environmental risk factors and biomarkers for autism spectrum disorder: an umbrella review of the evidence. The Lancet. Psychiatry. 6: 590-600. PMID 31230684 DOI: 10.1016/S2215-0366(19)30181-6  0.557
2019 Oliver D, Reilly TJ, Baccaredda Boy O, Petros N, Davies C, Borgwardt S, McGuire P, Fusar-Poli P. What Causes the Onset of Psychosis in Individuals at Clinical High Risk? A Meta-analysis of Risk and Protective Factors. Schizophrenia Bulletin. PMID 31219164 DOI: 10.1093/Schbul/Sbz039  0.769
2019 Bykowsky O, Harrisberger F, Schmidt A, Smieskova R, Hauke DJ, Egloff L, Riecher-Rössler A, Fusar-Poli P, Huber CG, Lang UE, Andreou C, Borgwardt S. Association of antidepressants with brain morphology in early stages of psychosis: an imaging genomics approach. Scientific Reports. 9: 8516. PMID 31186482 DOI: 10.1038/S41598-019-44903-Y  0.388
2019 Malda A, Boonstra N, Barf H, de Jong S, Aleman A, Addington J, Pruessner M, Nieman D, de Haan L, Morrison A, Riecher-Rössler A, Studerus E, Ruhrmann S, Schultze-Lutter F, An SK, ... ... Fusar-Poli P, et al. Individualized Prediction of Transition to Psychosis in 1,676 Individuals at Clinical High Risk: Development and Validation of a Multivariable Prediction Model Based on Individual Patient Data Meta-Analysis. Frontiers in Psychiatry. 10: 345. PMID 31178767 DOI: 10.3389/Fpsyt.2019.00345  0.419
2019 Fullana MA, Tortella-Feliu M, Fernández de la Cruz L, Chamorro J, Pérez-Vigil A, Ioannidis JPA, Solanes A, Guardiola M, Almodóvar C, Miranda-Olivos R, Ramella-Cravaro V, Vilar A, Reichenberg A, Mataix-Cols D, Vieta E, ... Fusar-Poli P, et al. Risk and protective factors for anxiety and obsessive-compulsive disorders: an umbrella review of systematic reviews and meta-analyses. Psychological Medicine. 1-16. PMID 31172897 DOI: 10.1017/S0033291719001247  0.639
2019 Fusar-Poli P, Davies C, Rutigliano G, Stahl D, Bonoldi I, McGuire P. Transdiagnostic Individualized Clinically Based Risk Calculator for the Detection of Individuals at Risk and the Prediction of Psychosis: Model Refinement Including Nonlinear Effects of Age. Frontiers in Psychiatry. 10: 313. PMID 31143134 DOI: 10.3389/Fpsyt.2019.00313  0.764
2019 Bonoldi I, Allen P, Madeira L, Tognin S, Bossong MG, Azis M, Samson C, Quinn B, Calem M, Valmaggia L, Modinos G, Stone J, Perez J, Howes O, Politi P, ... ... Fusar-Poli P, et al. Basic Self-Disturbances Related to Reduced Anterior Cingulate Volume in Subjects at Ultra-High Risk for Psychosis. Frontiers in Psychiatry. 10: 254. PMID 31133887 DOI: 10.3389/Fpsyt.2019.00254  0.459
2019 Fusar-Poli P, Solmi M, Brondino N, Davies C, Chae C, Politi P, Borgwardt S, Lawrie SM, Parnas J, McGuire P. Transdiagnostic psychiatry: a systematic review. World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 18: 192-207. PMID 31059629 DOI: 10.1002/Wps.20631  0.72
2019 Oliver D, Radua J, Reichenberg A, Uher R, Fusar-Poli P. Psychosis Polyrisk Score (PPS) for the Detection of Individuals At-Risk and the Prediction of Their Outcomes. Frontiers in Psychiatry. 10: 174. PMID 31057431 DOI: 10.3389/Fpsyt.2019.00174  0.593
2019 Fusar-Poli P, Oliver D, Spada G, Patel R, Stewart R, Dobson R, McGuire P. Real World Implementation of a Transdiagnostic Risk Calculator for the Automatic Detection of Individuals at Risk of Psychosis in Clinical Routine: Study Protocol. Frontiers in Psychiatry. 10: 109. PMID 30949070 DOI: 10.3389/Fpsyt.2019.00109  0.541
2019 Petros N, Mechelli A, Fusar-Poli P, Vieira S, Rowland E, McGuire P. Towards a framework for good outcome in people at clinical high risk for psychosis: A Delphi consensus study. Schizophrenia Research. PMID 30948149 DOI: 10.1016/J.Schres.2019.02.019  0.527
2019 Davies C, Rutigliano G, De Micheli A, Stone JM, Ramella-Cravaro V, Provenzani U, Cappucciati M, Scutt E, Paloyelis Y, Oliver D, Murguia S, Zelaya F, Allen P, Shergill S, Morrison P, ... ... Fusar-Poli P, et al. Neurochemical effects of oxytocin in people at clinical high risk for psychosis. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 30928180 DOI: 10.1016/J.Euroneuro.2019.03.008  0.736
2019 Kotlicka-Antczak M, Karbownik MS, Stawiski K, Pawełczyk A, Żurner N, Pawełczyk T, Strzelecki D, Fusar-Poli P. Short clinically-based prediction model to forecast transition to psychosis in individuals at clinical high risk state. European Psychiatry : the Journal of the Association of European Psychiatrists. 58: 72-79. PMID 30870626 DOI: 10.1016/J.Eurpsy.2019.02.007  0.414
2019 Minichino A, Rutigliano G, Merlino S, Davies C, Oliver D, De Micheli A, Patel R, McGuire P, Fusar-Poli P. Unmet needs in patients with brief psychotic disorders: Too ill for clinical high risk services and not ill enough for first episode services. European Psychiatry : the Journal of the Association of European Psychiatrists. 57: 26-32. PMID 30658277 DOI: 10.1016/J.Eurpsy.2018.12.006  0.768
2019 Davies C, Paloyelis Y, Rutigliano G, Cappucciati M, De Micheli A, Ramella-Cravaro V, Provenzani U, Antoniades M, Modinos G, Oliver D, Stahl D, Murguia S, Zelaya F, Allen P, Shergill S, ... ... Fusar-Poli P, et al. Oxytocin modulates hippocampal perfusion in people at clinical high risk for psychosis. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 30626906 DOI: 10.1038/S41386-018-0311-6  0.735
2019 Kempton M, Valmaggia L, Calem M, Tognin S, Modinos G, Fusar-poli P, Antoniades M, Gaag MVd, Haan LD, Nelson B, Riecher-Rössler A, Bressan R, Barrantes-Vidal N, Krebs M, Nordentoft M, et al. O6.5. Investigating Variables From The Napls Risk Calculator For Psychosis In The Eu-Gei High Risk Study Schizophrenia Bulletin. 45. DOI: 10.1093/Schbul/Sbz021.221  0.485
2019 Davies C, Rutigliano G, Micheli AD, Stone JM, Ramella-Cravaro V, Provenzani U, Cappucciati M, McGuire P, Fusar-Poli P. F94. Effects Of Oxytocin On Neurochemical Metabolites In Psychosis Risk Schizophrenia Bulletin. 45. DOI: 10.1093/Schbul/Sbz018.506  0.724
2019 Lin Y, Fusar-Poli P, Borgwardt S. Neuroimaging and the At-Risk Mental State Early Intervention in Psychiatry. 2: 219-265. DOI: 10.1007/978-3-319-97307-4_6  0.377
2018 Byrne M, Codjoe L, Morgan C, Stahl D, Day F, Fearon P, Fusar-Poli P, Power P, McGuire P, Valmaggia L. The relationship between ethnicity and service access, treatment uptake and the incidence of psychosis among people at ultra high risk for psychosis. Psychiatry Research. 272: 618-627. PMID 30616132 DOI: 10.1016/J.Psychres.2018.12.111  0.487
2018 Fusar-Poli P, Hijazi Z, Stahl D, Steyerberg EW. The Science of Prognosis in Psychiatry: A Review. Jama Psychiatry. PMID 30347013 DOI: 10.1001/Jamapsychiatry.2018.2530  0.301
2018 Fusar-Poli P, Davies C, Bonoldi I. A Case of a College Student Presenting With Mild Mental Health Problems. Jama Psychiatry. PMID 30347005 DOI: 10.1001/Jamapsychiatry.2018.2486  0.645
2018 Harrisberger F, Smieskova R, Egli T, Simon AE, Riecher-Rössler A, Fusar-Poli P, Papassotiropoulos A, Borgwardt S. Impact on the Onset of Psychosis of a Polygenic Schizophrenia-Related Risk Score and Changes in White Matter Volume. Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology. 48: 1201-1214. PMID 30045020 DOI: 10.1159/000491986  0.38
2018 Fusar-Poli P, Radua J. Ten simple rules for conducting umbrella reviews. Evidence-Based Mental Health. PMID 30006442 DOI: 10.1136/Ebmental-2018-300014  0.489
2018 Davies C, Radua J, Cipriani A, Stahl D, Provenzani U, McGuire P, Fusar-Poli P. Efficacy and Acceptability of Interventions for Attenuated Positive Psychotic Symptoms in Individuals at Clinical High Risk of Psychosis: A Network Meta-Analysis. Frontiers in Psychiatry. 9: 187. PMID 29946270 DOI: 10.3389/Fpsyt.2018.00187  0.782
2018 Fusar-Poli P, Werbeloff N, Rutigliano G, Oliver D, Davies C, Stahl D, McGuire P, Osborn D. Transdiagnostic Risk Calculator for the Automatic Detection of Individuals at Risk and the Prediction of Psychosis: Second Replication in an Independent National Health Service Trust. Schizophrenia Bulletin. PMID 29897527 DOI: 10.1093/Schbul/Sby070  0.759
2018 Davies C, Cipriani A, Ioannidis JPA, Radua J, Stahl D, Provenzani U, McGuire P, Fusar-Poli P. Lack of evidence to favor specific preventive interventions in psychosis: a network meta-analysis. World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 17: 196-209. PMID 29856551 DOI: 10.1002/Wps.20526  0.776
2018 Rutigliano G, Merlino S, Minichino A, Patel R, Davies C, Oliver D, De Micheli A, McGuire P, Fusar-Poli P. Long term outcomes of acute and transient psychotic disorders: The missed opportunity of preventive interventions. European Psychiatry : the Journal of the Association of European Psychiatrists. 52: 126-133. PMID 29787962 DOI: 10.1016/J.Eurpsy.2018.05.004  0.733
2018 David SP, Naudet F, Laude J, Radua J, Fusar-Poli P, Chu I, Stefanick ML, Ioannidis JPA. Potential Reporting Bias in Neuroimaging Studies of Sex Differences. Scientific Reports. 8: 6082. PMID 29666377 DOI: 10.1038/S41598-018-23976-1  0.487
2018 Fusar-Poli P, De Micheli A, Rocchetti M, Cappucciati M, Ramella-Cravaro V, Rutigliano G, Bonoldi I, McGuire P, Falkenberg I. Semistructured Interview for Bipolar At Risk States (SIBARS). Psychiatry Research. 264: 302-309. PMID 29665559 DOI: 10.1016/J.Psychres.2018.03.074  0.539
2018 Reilly TJ, Nottage JF, Studerus E, Rutigliano G, Micheli AI, Fusar-Poli P, McGuire P. Gamma Band Oscillations in the Early Phase of Psychosis: A Systematic Review. Neuroscience and Biobehavioral Reviews. PMID 29656029 DOI: 10.1016/J.Neubiorev.2018.04.006  0.462
2018 Oliver D, Kotlicka-Antczak M, Minichino A, Spada G, McGuire P, Fusar-Poli P. Meta-analytical prognostic accuracy of the Comprehensive Assessment of at Risk Mental States (CAARMS): The need for refined prediction. European Psychiatry : the Journal of the Association of European Psychiatrists. 49: 62-68. PMID 29413807 DOI: 10.1016/J.Eurpsy.2017.10.001  0.533
2018 Oliver D, Davies C, Crossland G, Lim S, Gifford G, McGuire P, Fusar-Poli P. Can We Reduce the Duration of Untreated Psychosis? A Systematic Review and Meta-Analysis of Controlled Interventional Studies. Schizophrenia Bulletin. PMID 29373755 DOI: 10.1093/Schbul/Sbx166  0.731
2018 Radua J, Ramella-Cravaro V, Ioannidis JPA, Reichenberg A, Phiphopthatsanee N, Amir T, Yenn Thoo H, Oliver D, Davies C, Morgan C, McGuire P, Murray RM, Fusar-Poli P. What causes psychosis? An umbrella review of risk and protective factors. World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 17: 49-66. PMID 29352556 DOI: 10.1002/Wps.20490  0.784
2018 Davies C, Rutigliano G, Cappucciati M, De Micheli A, Ramella-Cravaro V, Provenzani U, Schmidt A, Paloyelis Y, McGuire P, Fusar-poli P. S149. EFFECTS OF INTRANASAL OXYTOCIN ON RESTING CEREBRAL BLOOD FLOW IN PEOPLE AT ULTRA-HIGH RISK FOR PSYCHOSIS Schizophrenia Bulletin. 44: S383-S383. DOI: 10.1093/Schbul/Sby018.936  0.719
2018 Petros N, Mechelli A, Fusar-Poli P, Vieira S, Rowland E, McGuire P. S126. GOOD OUTCOME IN INDIVIDUALS AT ULTRA-HIGH RISK (UHR) OF DEVELOPING PSYCHOSIS: A DELPHI STUDY Schizophrenia Bulletin. 44: S374-S374. DOI: 10.1093/Schbul/Sby018.913  0.496
2018 Oliver D, Davies C, Crossland G, Lim S, Gifford G, McGuire P, Fusar-Poli P. F256. CAN WE REDUCE THE DURATION OF UNTREATED PSYCHOSIS? Schizophrenia Bulletin. 44: S323-S323. DOI: 10.1093/Schbul/Sby017.787  0.684
2018 Minichino A, Rutigliano G, Merlino S, Davies C, Oliver D, De Micheli A, McGuire P, Fusar-Poli P. T122. UNMET NEEDS IN PATIENTS WITH ACUTE TRANSIENT PSYCHOTIC DISORDERS (ATPD): ANALYSIS OF PATHWAYS TO CARE: AN 8 YEARS FOLLOW-UP STUDY Schizophrenia Bulletin. 44: S162-S163. DOI: 10.1093/Schbul/Sby016.398  0.702
2018 Fusar-poli P, Rutigliano G, Stahl D, Davies C, Bonoldi I, Reilly T, McGuire P. 34.2 IMPROVING THE DETECTION OF INDIVIDUALS AT RISK OF PSYCHOSIS IN SECONDARY MENTAL HEALTH CARE Schizophrenia Bulletin. 44: S56-S57. DOI: 10.1093/Schbul/Sby014.143  0.727
2018 Fusar-poli P. 34. Improving The Detection Of Individuals At Risk Of Psychosis. Schizophrenia Bulletin. 44. DOI: 10.1093/Schbul/Sby014.141  0.436
2018 Fusar-Poli P. The Hype Cycle of the Clinical High Risk State for Psychosis: The Need of a Refined Approach Schizophrenia Bulletin. 44: 250-253. DOI: 10.1093/Schbul/Sbx181  0.368
2017 Winton-Brown T, Schmidt A, Roiser JP, Howes OD, Egerton A, Fusar-Poli P, Bunzeck N, Grace AA, Duzel E, Kapur S, McGuire P. Altered activation and connectivity in a hippocampal-basal ganglia-midbrain circuit during salience processing in subjects at ultra high risk for psychosis. Translational Psychiatry. 7: e1245. PMID 28972591 DOI: 10.1038/Tp.2017.174  0.482
2017 Mills JG, Fusar-Poli P, Morgan C, Azis M, McGuire P. People meeting ultra high risk for psychosis criteria in the community. World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 16: 322-323. PMID 28941095 DOI: 10.1002/Wps.20463  0.48
2017 Fusar-Poli P, McGorry PD, Kane JM. Improving outcomes of first-episode psychosis: an overview. World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 16: 251-265. PMID 28941089 DOI: 10.1002/Wps.20446  0.384
2017 Bhavsar V, McGuire P, MacCabe J, Oliver D, Fusar-Poli P. A systematic review and meta-analysis of mental health service use in people who report psychotic experiences. Early Intervention in Psychiatry. PMID 28805304 DOI: 10.1111/Eip.12464  0.436
2017 Castagnini AC, Fusar-Poli P. Diagnostic validity of ICD-10 acute and transient psychotic disorders and DSM-5 brief psychotic disorder European Psychiatry. 45: 104-113. PMID 28756108 DOI: 10.1016/J.Eurpsy.2017.05.028  0.379
2017 Fusar-Poli P, Palombini E, Davies C, Oliver D, Bonoldi I, Ramella-Cravaro V, McGuire P. Why transition risk to psychosis is not declining at the OASIS ultra high risk service: The hidden role of stable pretest risk enrichment. Schizophrenia Research. PMID 28734908 DOI: 10.1016/J.Schres.2017.06.015  0.753
2017 Demjaha A, Weinstein S, Stahl D, Day F, Valmaggia L, Rutigliano G, De Micheli A, Fusar-Poli P, McGuire P. Formal thought disorder in people at ultra-high risk of psychosis. Bjpsych Open. 3: 165-170. PMID 28713586 DOI: 10.1192/Bjpo.Bp.116.004408  0.527
2017 Bhavsar V, Fusar-Poli P, McGuire P. Neighbourhood deprivation is positively associated with detection of the ultra-high risk (UHR) state for psychosis in South East London. Schizophrenia Research. PMID 28601502 DOI: 10.1016/J.Schres.2017.06.006  0.529
2017 Fusar-Poli P, De Micheli A, Cappucciati M, Rutigliano G, Davies C, Ramella-Cravaro V, Oliver D, Bonoldi I, Rocchetti M, Gavaghan L, Patel R, McGuire P. Diagnostic and Prognostic Significance of DSM-5 Attenuated Psychosis Syndrome in Services for Individuals at Ultra High Risk for Psychosis. Schizophrenia Bulletin. PMID 28521060 DOI: 10.1093/Schbul/Sbx055  0.76
2017 Fusar-Poli P. Why ultra high risk criteria for psychosis prediction do not work well outside clinical samples and what to do about it. World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 16: 212-213. PMID 28498578 DOI: 10.1002/Wps.20405  0.366
2017 Dukart J, Smieskova R, Harrisberger F, Lenz C, Schmidt A, Walter A, Huber C, Riecher-Rössler A, Simon A, Lang UE, Fusar-Poli P, Borgwardt S. Age-related brain structural alterations as an intermediate phenotype of psychosis. Journal of Psychiatry & Neuroscience : Jpn. 42: 160179. PMID 28459416 DOI: 10.1503/Jpn.160179  0.377
2017 Fusar-Poli P, Rutigliano G, Stahl D, Davies C, Bonoldi I, Reilly T, McGuire P. Development and Validation of a Clinically Based Risk Calculator for the Transdiagnostic Prediction of Psychosis. Jama Psychiatry. PMID 28355424 DOI: 10.1001/Jamapsychiatry.2017.0284  0.748
2017 Fusar-Poli P, Cappucciati M, De Micheli A, Rutigliano G, Bonoldi I, Tognin S, Ramella-Cravaro V, Castagnini A, McGuire P. Diagnostic and Prognostic Significance of Brief Limited Intermittent Psychotic Symptoms (BLIPS) in Individuals at Ultra High Risk. Schizophrenia Bulletin. 43: 48-56. PMID 28053130 DOI: 10.1093/Schbul/Sbw151  0.524
2017 Fusar-Poli P. The Clinical High-Risk State for Psychosis (CHR-P), Version II. Schizophrenia Bulletin. 43: 44-47. PMID 28053129 DOI: 10.1093/Schbul/Sbw158  0.428
2016 Fusar-Poli P, Rutigliano G, Stahl D, Davies C, De Micheli A, Ramella-Cravaro V, Bonoldi I, McGuire P. Long-term validity of the At Risk Mental State (ARMS) for predicting psychotic and non-psychotic mental disorders. European Psychiatry : the Journal of the Association of European Psychiatrists. 42: 49-54. PMID 28212505 DOI: 10.1016/J.Eurpsy.2016.11.010  0.736
2016 Fusar-Poli P, Raballo A, Parnas J. What Is an Attenuated Psychotic Symptom? On the Importance of the Context. Schizophrenia Bulletin. PMID 28039421 DOI: 10.1093/Schbul/Sbw182  0.331
2016 Fusar-Poli P, Tantardini M, De Simone S, Ramella-Cravaro V, Oliver D, Kingdon J, Kotlicka-Antczak M, Valmaggia L, Lee J, Millan MJ, Galderisi S, Balottin U, Ricca V, McGuire P. Deconstructing vulnerability for psychosis: Meta-analysis of environmental risk factors for psychosis in subjects at ultra high-risk. European Psychiatry : the Journal of the Association of European Psychiatrists. 40: 65-75. PMID 27992836 DOI: 10.1016/J.Eurpsy.2016.09.003  0.531
2016 Fusar-Poli P, Rutigliano G, Stahl D, Schmidt A, Ramella-Cravaro V, Hitesh S, McGuire P. Deconstructing Pretest Risk Enrichment to Optimize Prediction of Psychosis in Individuals at Clinical High Risk. Jama Psychiatry. PMID 27784037 DOI: 10.1001/Jamapsychiatry.2016.2707  0.529
2016 Schmidt A, Antoniades M, Allen P, Egerton A, Chaddock CA, Borgwardt S, Fusar-Poli P, Roiser JP, Howes O, McGuire P. Longitudinal alterations in motivational salience processing in ultra-high-risk subjects for psychosis. Psychological Medicine. 1-12. PMID 27697078 DOI: 10.1017/S0033291716002439  0.536
2016 Falkenberg I, Valli I, Raffin M, Broome MR, Fusar-Poli P, Matthiasson P, Picchioni M, McGuire P. Pattern of activation during delayed matching to sample task predicts functional outcome in people at ultra high risk for psychosis. Schizophrenia Research. PMID 27693282 DOI: 10.1016/J.Schres.2016.09.023  0.519
2016 Schmidt A, Cappucciati M, Radua J, Rutigliano G, Rocchetti M, Dell'Osso L, Politi P, Borgwardt S, Reilly T, Valmaggia L, McGuire P, Fusar-Poli P. Improving Prognostic Accuracy in Subjects at Clinical High Risk for Psychosis: Systematic Review of Predictive Models and Meta-analytical Sequential Testing Simulation. Schizophrenia Bulletin. PMID 27535081 DOI: 10.1093/Schbul/Sbw098  0.609
2016 Schmidt A, Crossley NA, Harrisberger F, Smieskova R, Lenz C, Riecher-Rössler A, Lang UE, McGuire P, Fusar-Poli P, Borgwardt S. Structural Network Disorganization in Subjects at Clinical High Risk for Psychosis. Schizophrenia Bulletin. PMID 27481826 DOI: 10.1093/Schbul/Sbw110  0.502
2016 Fusar-Poli P, Cappucciati M, Rutigliano G, Lee TY, Beverly Q, Bonoldi I, Lelli J, Kaar SJ, Gago E, Rocchetti M, Patel R, Bhavsar V, Tognin S, Badger S, Calem M, et al. Towards a Standard Psychometric Diagnostic Interview for Subjects at Ultra High Risk of Psychosis: CAARMS versus SIPS. Psychiatry Journal. 2016: 7146341. PMID 27314005 DOI: 10.1155/2016/7146341  0.495
2016 Rutigliano G, Valmaggia L, Landi P, Frascarelli M, Cappucciati M, Sear V, Rocchetti M, De Micheli A, Jones C, Palombini E, McGuire P, Fusar-Poli P. Persistence or recurrence of non-psychotic comorbid mental disorders associated with 6-year poor functional outcomes in patients at ultra high risk for psychosis. Journal of Affective Disorders. 203: 101-110. PMID 27285723 DOI: 10.1016/J.Jad.2016.05.053  0.522
2016 Rutigliano G, Rocchetti M, Paloyelis Y, Gilleen J, Sardella A, Cappucciati M, Palombini E, Dell'Osso L, Caverzasi E, Politi P, McGuire P, Fusar-Poli P. Peripheral oxytocin and vasopressin: Biomarkers of psychiatric disorders? A comprehensive systematic review and preliminary meta-analysis. Psychiatry Research. 241: 207-220. PMID 27183106 DOI: 10.1016/J.Psychres.2016.04.117  0.454
2016 Madeira L, Bonoldi I, Rocchetti M, Brandizzi M, Samson C, Azis M, Queen B, Bossong M, Allen P, Perez J, Howes OD, McGuire P, Fusar-Poli P. Prevalence and implications of Truman symptoms in subjects at ultra high risk for psychosis. Psychiatry Research. 238: 270-6. PMID 27086244 DOI: 10.1016/J.Psychres.2016.02.001  0.507
2016 Gifford G, Crossley N, Fusar-Poli P, Schnack HG, Kahn RS, Koutsouleris N, Cannon TD, McGuire P. Using neuroimaging to help predict the onset of psychosis. Neuroimage. PMID 27039698 DOI: 10.1016/J.Neuroimage.2016.03.075  0.544
2016 Jarrett M, Jamieson-Craig TK, Forrester A, McGuire P, Badger S, Fusar-Poli P, Byrne M, Williams P, Valmaggia LR. Prison and Community Populations at Ultra-High Risk of Psychosis: Differences and Challenges for Service Provision. Psychiatric Services (Washington, D.C.). appips201500355. PMID 27032664 DOI: 10.1176/Appi.Ps.201500355  0.43
2016 Madeira L, Bonoldi I, Rocchetti M, Samson C, Azis M, Queen B, Bossong M, Perez J, Stone J, Allen P, Howes OD, McGuire P, Raballo A, Fusar-Poli P, Ballerini M, et al. An initial investigation of abnormal bodily phenomena in subjects at ultra high risk for psychosis: Their prevalence and clinical implications. Comprehensive Psychiatry. 66: 39-45. PMID 26995234 DOI: 10.1016/J.Comppsych.2015.12.005  0.516
2016 Fusar-Poli P, Cappucciati M, Rutigliano G, Heslin M, Stahl D, Brittenden Z, Caverzasi E, McGuire P, Carpenter WT. Diagnostic Stability of ICD/DSM First Episode Psychosis Diagnoses: Meta-analysis. Schizophrenia Bulletin. PMID 26980142 DOI: 10.1093/Schbul/Sbw020  0.466
2016 Millan MJ, Andrieux A, Bartzokis G, Cadenhead K, Dazzan P, Fusar-Poli P, Gallinat J, Giedd J, Grayson DR, Heinrichs M, Kahn R, Krebs MO, Leboyer M, Lewis D, Marin O, et al. Altering the course of schizophrenia: progress and perspectives. Nature Reviews. Drug Discovery. PMID 26939910 DOI: 10.1038/Nrd.2016.28  0.518
2016 Schmidt A, Palaniyappan L, Smieskova R, Simon A, Riecher-Rössler A, Lang UE, Fusar-Poli P, McGuire P, Borgwardt SJ. Dysfunctional insular connectivity during reward prediction in patients with first-episode psychosis. Journal of Psychiatry & Neuroscience : Jpn. 41: 150234. PMID 26854756 DOI: 10.1503/Jpn.150234  0.439
2016 Fusar-Poli P, Schultze-Lutter F, Addington J. Intensive community outreach for those at ultra high risk of psychosis: dilution, not solution. The Lancet. Psychiatry. 3: 18. PMID 26772061 DOI: 10.1016/S2215-0366(15)00491-5  0.3
2016 Fusar-Poli P, Cappucciati M, Bonoldi I, Hui LM, Rutigliano G, Stahl DR, Borgwardt S, Politi P, Mishara AL, Lawrie SM, Carpenter WT, McGuire PK. Prognosis of Brief Psychotic Episodes: A Meta-analysis. Jama Psychiatry. 1-10. PMID 26764163 DOI: 10.1001/Jamapsychiatry.2015.2313  0.481
2016 Fusar-Poli P, Schultze-Lutter F. Predicting the onset of psychosis in patients at clinical high risk: Practical guide to probabilistic prognostic reasoning Evidence-Based Mental Health. 19: 10-15. DOI: 10.1136/Eb-2015-102295  0.397
2015 Fusar-Poli P, Cappucciati M, Borgwardt S, Woods SW, Addington J, Nelson B, Nieman DH, Stahl DR, Rutigliano G, Riecher-Rössler A, Simon AE, Mizuno M, Lee TY, Kwon JS, Lam MM, et al. Heterogeneity of Psychosis Risk Within Individuals at Clinical High Risk: A Meta-analytical Stratification. Jama Psychiatry. 1-8. PMID 26719911 DOI: 10.1001/Jamapsychiatry.2015.2324  0.543
2015 Schmidt A, Lenz C, Smieskova R, Harrisberger F, Walter A, Riecher-Rössler A, Simon A, Lang UE, McGuire P, Fusar-Poli P, Borgwardt SJ. Brain Diffusion Changes in Emerging Psychosis and the Impact of State-Dependent Psychopathology. Neuro-Signals. 23: 71-83. PMID 26682550 DOI: 10.1159/000442605  0.495
2015 Fusar-Poli P, Schultze-Lutter F, Cappucciati M, Rutigliano G, Bonoldi I, Stahl D, Borgwardt S, Riecher-Rössler A, Addington J, Perkins DO, Woods SW, McGlashan T, Lee J, Klosterkötter J, Yung AR, et al. The Dark Side of the Moon: Meta-analytical Impact of Recruitment Strategies on Risk Enrichment in the Clinical High Risk State for Psychosis. Schizophrenia Bulletin. PMID 26591006 DOI: 10.1093/Schbul/Sbv162  0.532
2015 Radua J, Schmidt A, Borgwardt S, Heinz A, Schlagenhauf F, McGuire P, Fusar-Poli P. Ventral Striatal Activation During Reward Processing in Psychosis: A Neurofunctional Meta-Analysis. Jama Psychiatry. 1243-1251. PMID 26558708 DOI: 10.1001/Jamapsychiatry.2015.2196  0.613
2015 Fusar-Poli P, Cappucciati M, Rutigliano G, Schultze-Lutter F, Bonoldi I, Borgwardt S, Riecher-Rössler A, Addington J, Perkins D, Woods SW, McGlashan TH, Lee J, Klosterkötter J, Yung AR, McGuire P. At risk or not at risk? A meta-analysis of the prognostic accuracy of psychometric interviews for psychosis prediction. World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 14: 322-32. PMID 26407788 DOI: 10.1002/Wps.20250  0.535
2015 Mishara A, Bonoldi I, Allen P, Rutigliano G, Perez J, Fusar-Poli P, McGuire P. Neurobiological Models of Self-Disorders in Early Schizophrenia. Schizophrenia Bulletin. PMID 26385763 DOI: 10.1093/Schbul/Sbv123  0.477
2015 Fusar-Poli P, Díaz-Caneja CM, Patel R, Valmaggia L, Byrne M, Garety P, Shetty H, Broadbent M, Stewart R, McGuire P. Services for people at high risk improve outcomes in patients with first episode psychosis. Acta Psychiatrica Scandinavica. PMID 26358300 DOI: 10.1111/Acps.12480  0.504
2015 Valmaggia LR, Day FL, Kroll J, Laing J, Byrne M, Fusar-Poli P, McGuire P. Bullying victimisation and paranoid ideation in people at ultra high risk for psychosis. Schizophrenia Research. 168: 68-73. PMID 26351160 DOI: 10.1016/J.Schres.2015.08.029  0.523
2015 Fusar-Poli P, Rocchetti M, Sardella A, Avila A, Brandizzi M, Caverzasi E, Politi P, Ruhrmann S, McGuire P. Disorder, not just state of risk: meta-analysis of functioning and quality of life in people at high risk of psychosis. The British Journal of Psychiatry : the Journal of Mental Science. 207: 198-206. PMID 26329563 DOI: 10.1192/Bjp.Bp.114.157115  0.535
2015 Fusar-Poli P. The Enduring Search for the Koplik Spots of Psychosis. Jama Psychiatry. PMID 26266967 DOI: 10.1001/Jamapsychiatry.2015.0611  0.374
2015 Bernasconi R, Smieskova R, Schmidt A, Harrisberger F, Raschle NM, Lenz C, Walter A, Simon A, Riecher-Rössler A, Radue EW, Lang UE, Fusar-Poli P, Borgwardt SJ. Hippocampal volume correlates with attenuated negative psychotic symptoms irrespective of antidepressant medication. Neuroimage. Clinical. 8: 230-7. PMID 26110110 DOI: 10.1016/J.Nicl.2015.04.016  0.363
2015 Falkenberg I, Valmaggia L, Byrnes M, Frascarelli M, Jones C, Rocchetti M, Straube B, Badger S, McGuire P, Fusar-Poli P. Why are help-seeking subjects at ultra-high risk for psychosis help-seeking? Psychiatry Research. PMID 26071897 DOI: 10.1016/J.Psychres.2015.05.018  0.53
2015 Valmaggia LR, Byrne M, Day F, Broome MR, Johns L, Howes O, Power P, Badger S, Fusar-Poli P, McGuire PK. Duration of untreated psychosis and need for admission in patients who engage with mental health services in the prodromal phase. The British Journal of Psychiatry : the Journal of Mental Science. PMID 26045348 DOI: 10.1192/Bjp.Bp.114.150623  0.433
2015 Smieskova R, Roiser JP, Chaddock CA, Schmidt A, Harrisberger F, Bendfeldt K, Simon A, Walter A, Fusar-Poli P, McGuire PK, Lang UE, Riecher-Rössler A, Borgwardt S. Modulation of motivational salience processing during the early stages of psychosis. Schizophrenia Research. PMID 25999039 DOI: 10.1016/J.Schres.2015.04.036  0.427
2015 Spada G, Molteni S, Pistone C, Chiappedi M, McGuire P, Fusar-Poli P, Balottin U. Identifying children and adolescents at ultra high risk of psychosis in Italian neuropsychiatry services: a feasibility study. European Child & Adolescent Psychiatry. PMID 25925786 DOI: 10.1007/S00787-015-0710-8  0.518
2015 Kempton MJ, Bonoldi I, Valmaggia L, McGuire P, Fusar-Poli P. Speed of Psychosis Progression in People at Ultra-High Clinical Risk: A Complementary Meta-analysis. Jama Psychiatry. 72: 622-3. PMID 25901658 DOI: 10.1001/Jamapsychiatry.2015.0094  0.522
2015 Brandizzi M, Valmaggia L, Byrne M, Jones C, Iwegbu N, Badger S, McGuire P, Fusar-Poli P. Predictors of functional outcome in individuals at high clinical risk for psychosis at six years follow-up. Journal of Psychiatric Research. 65: 115-23. PMID 25837413 DOI: 10.1016/J.Jpsychires.2015.03.005  0.494
2015 Shaikh M, Dutt A, Broome MR, Vozmediano AG, Ranlund S, Diez A, Caseiro O, Lappin J, Amankwa S, Carletti F, Fusar-Poli P, Walshe M, Hall MH, Howes O, Ellett L, et al. Sensory gating deficits in the attenuated psychosis syndrome. Schizophrenia Research. 161: 277-82. PMID 25556079 DOI: 10.1016/J.Schres.2014.12.021  0.482
2015 Fusar-Poli P, Papanastasiou E, Stahl D, Rocchetti M, Carpenter W, Shergill S, McGuire P. Treatments of Negative Symptoms in Schizophrenia: Meta-Analysis of 168 Randomized Placebo-Controlled Trials. Schizophrenia Bulletin. 41: 892-9. PMID 25528757 DOI: 10.1093/Schbul/Sbu170  0.463
2015 Wigton R, Radua J, Allen P, Averbeck B, Meyer-Lindenberg A, McGuire P, Shergill SS, Fusar-Poli P. Neurophysiological effects of acute oxytocin administration: systematic review and meta-analysis of placebo-controlled imaging studies. Journal of Psychiatry & Neuroscience : Jpn. 40: E1-22. PMID 25520163 DOI: 10.1503/Jpn.130289  0.608
2015 Frascarelli M, Tognin S, Mirigliani A, Parente F, Buzzanca A, Torti MC, Tinelli E, Caramia F, Di Fabio F, Biondi M, Fusar-Poli P. Medial frontal gyrus alterations in schizophrenia: relationship with duration of illness and executive dysfunction. Psychiatry Research. 231: 103-10. PMID 25498920 DOI: 10.1016/J.Pscychresns.2014.10.017  0.343
2015 Fusar-Poli P, Frascarelli M, Valmaggia L, Byrne M, Stahl D, Rocchetti M, Codjoe L, Weinberg L, Tognin S, Xenaki L, McGuire P. Antidepressant, antipsychotic and psychological interventions in subjects at high clinical risk for psychosis: OASIS 6-year naturalistic study. Psychological Medicine. 45: 1327-39. PMID 25335776 DOI: 10.1017/S003329171400244X  0.506
2015 Allen P, Chaddock CA, Egerton A, Howes OD, Barker G, Bonoldi I, Fusar-Poli P, Murray R, McGuire P. Functional outcome in people at high risk for psychosis predicted by thalamic glutamate levels and prefronto-striatal activation. Schizophrenia Bulletin. 41: 429-39. PMID 25123110 DOI: 10.1093/Schbul/Sbu115  0.492
2015 Walter M, Denier N, Gerber H, Schmid O, Lanz C, Brenneisen R, Riecher-Rössler A, Wiesbeck GA, Scheffler K, Seifritz E, McGuire P, Fusar-Poli P, Borgwardt S. Orbitofrontal response to drug-related stimuli after heroin administration. Addiction Biology. 20: 570-9. PMID 24720731 DOI: 10.1111/Adb.12145  0.421
2015 Avila A, Rocchetti M, Sardella A, Fusar-Poli P. Meta-analysis of Quality of Life Data in Subjects at High Risk for Psychosis. European Psychiatry. 30: 284. DOI: 10.1016/S0924-9338(15)31864-2  0.377
2015 Bonoldi I, Allen P, Tognin S, Madeira L, Azis M, Samson C, Quinn B, Modinos G, Bossong M, Stone J, Perez J, Howes O, Fusar-Poli P, McGuire P. Gray Matter Reductions in Cortical Midline Structures Related to Basic Self Disturbances in People at “ultra High Risk” for Psychosis European Psychiatry. 30: 297. DOI: 10.1016/S0924-9338(15)30239-X  0.321
2015 Fusar-Poli P. Affective Comorbidities in People at High Risk for Psychosis European Psychiatry. 30: 23. DOI: 10.1016/S0924-9338(15)30018-3  0.352
2014 Schmidt A, Diwadkar VA, Smieskova R, Harrisberger F, Lang UE, McGuire P, Fusar-Poli P, Borgwardt S. Approaching a network connectivity-driven classification of the psychosis continuum: a selective review and suggestions for future research. Frontiers in Human Neuroscience. 8: 1047. PMID 25628553 DOI: 10.3389/Fnhum.2014.01047  0.513
2014 Modinos G, Allen P, Frascarelli M, Tognin S, Valmaggia L, Xenaki L, Keedwell P, Broome M, Valli I, Woolley J, Stone JM, Mechelli A, Phillips ML, McGuire P, Fusar-Poli P. Are we really mapping psychosis risk? Neuroanatomical signature of affective disorders in subjects at ultra high risk. Psychological Medicine. 44: 3491-501. PMID 25066827 DOI: 10.1017/S0033291714000865  0.53
2014 Valmaggia LR, Day FL, Jones C, Bissoli S, Pugh C, Hall D, Bhattacharyya S, Howes O, Stone J, Fusar-Poli P, Byrne M, McGuire PK. Cannabis use and transition to psychosis in people at ultra-high risk. Psychological Medicine. 44: 2503-12. PMID 25055169 DOI: 10.1017/S0033291714000117  0.524
2014 Schlögelhofer M, Amminger GP, Schaefer MR, Fusar-Poli P, Smesny S, McGorry P, Berger G, Mossaheb N. Polyunsaturated fatty acids in emerging psychosis: a safer alternative? Early Intervention in Psychiatry. 8: 199-208. PMID 24861004 DOI: 10.1111/Eip.12151  0.328
2014 Rocchetti M, Radua J, Paloyelis Y, Xenaki LA, Frascarelli M, Caverzasi E, Politi P, Fusar-Poli P. Neurofunctional maps of the 'maternal brain' and the effects of oxytocin: a multimodal voxel-based meta-analysis. Psychiatry and Clinical Neurosciences. 68: 733-51. PMID 24734987 DOI: 10.1111/Pcn.12185  0.423
2014 Reynolds N, Wuyts P, Badger S, Fusar-Poli P, McGuire P, Valmaggia L. The impact of delivering GP training on the clinical high risk and first-episode psychosis on referrals and pathways to care. Early Intervention in Psychiatry. PMID 24602226 DOI: 10.1111/Eip.12126  0.438
2014 Radua J, Rubia K, Canales-Rodríguez EJ, Pomarol-Clotet E, Fusar-Poli P, Mataix-Cols D. Anisotropic kernels for coordinate-based meta-analyses of neuroimaging studies. Frontiers in Psychiatry. 5: 13. PMID 24575054 DOI: 10.3389/Fpsyt.2014.00013  0.594
2014 Schmidt A, Smieskova R, Simon A, Allen P, Fusar-Poli P, McGuire PK, Bendfeldt K, Aston J, Lang UE, Walter M, Radue EW, Riecher-Rössler A, Borgwardt SJ. Abnormal effective connectivity and psychopathological symptoms in the psychosis high-risk state. Journal of Psychiatry & Neuroscience : Jpn. 39: 239-48. PMID 24506946 DOI: 10.1503/Jpn.130102  0.508
2014 Fusar-Poli P, Carpenter WT, Woods SW, McGlashan TH. Attenuated psychosis syndrome: ready for DSM-5.1? Annual Review of Clinical Psychology. 10: 155-92. PMID 24471375 DOI: 10.1146/Annurev-Clinpsy-032813-153645  0.393
2014 Winton-Brown TT, Fusar-Poli P, Ungless MA, Howes OD. Dopaminergic basis of salience dysregulation in psychosis. Trends in Neurosciences. 37: 85-94. PMID 24388426 DOI: 10.1016/J.Tins.2013.11.003  0.306
2014 Schubart CD, Sommer IE, Fusar-Poli P, de Witte L, Kahn RS, Boks MP. Cannabidiol as a potential treatment for psychosis. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 24: 51-64. PMID 24309088 DOI: 10.1016/J.Euroneuro.2013.11.002  0.396
2014 Cooper D, Barker V, Radua J, Fusar-Poli P, Lawrie SM. Multimodal voxel-based meta-analysis of structural and functional magnetic resonance imaging studies in those at elevated genetic risk of developing schizophrenia. Psychiatry Research. 221: 69-77. PMID 24239093 DOI: 10.1016/J.Pscychresns.2013.07.008  0.574
2014 Fusar-Poli P, Radua J, Frascarelli M, Mechelli A, Borgwardt S, Di Fabio F, Biondi M, Ioannidis JP, David SP. Evidence of reporting biases in voxel-based morphometry (VBM) studies of psychiatric and neurological disorders. Human Brain Mapping. 35: 3052-65. PMID 24123491 DOI: 10.1002/Hbm.22384  0.519
2014 Fusar-Poli P, Yung AR, McGorry P, van Os J. Lessons learned from the psychosis high-risk state: towards a general staging model of prodromal intervention. Psychological Medicine. 44: 17-24. PMID 23414600 DOI: 10.1017/S0033291713000184  0.43
2014 Samartzis L, Dima D, Fusar-Poli P, Kyriakopoulos M. White matter alterations in early stages of schizophrenia: a systematic review of diffusion tensor imaging studies. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. 24: 101-10. PMID 23317110 DOI: 10.1111/J.1552-6569.2012.00779.X  0.356
2014 Fusar-Poli P, Nelson B, Valmaggia L, Yung AR, McGuire PK. Comorbid depressive and anxiety disorders in 509 individuals with an at-risk mental state: impact on psychopathology and transition to psychosis. Schizophrenia Bulletin. 40: 120-31. PMID 23180756 DOI: 10.1093/Schbul/Sbs136  0.493
2014 Fusar-Poli P, Smieskova R, Serafini G, Politi P, Borgwardt S. Neuroanatomical markers of genetic liability to psychosis and first episode psychosis: a voxelwise meta-analytical comparison. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 15: 219-28. PMID 22283467 DOI: 10.3109/15622975.2011.630408  0.358
2014 Frascarelli M, Valmaggia L, Byrne M, Codjoe L, Weinberg L, Tognin S, Lida X, McGuire P, Fusar-Poli P. Poster #M145 FOCUSED INTERVENTIONS IN 258 SUBJECTS AT HIGH CLINICAL RISK FOR PSYCHOSIS: OASIS 6-YEARS NATURALISTIC STUDY Schizophrenia Research. 153. DOI: 10.1016/S0920-9964(14)70695-4  0.497
2014 Schmidt A, Smieskova R, Allen P, Fusar-Poli P, McGuire P, Lang U, Walter M, Radue ER, Riecher-Rössler A, Borgwardt S. Poster #M40 THE RELATION OF ABNORMAL BRAIN CONNECTIVITY AND PSYCHIATRIC SYMPTOM EXPRESSION IN SUBJECTS AT HIGH-RISK FOR PSYCHOSIS Schizophrenia Research. 153. DOI: 10.1016/S0920-9964(14)70590-0  0.49
2014 Frascarelli M, Tognin S, Mirigliani A, Parente F, Antonino B, Torti MC, Francesca C, Fabio FD, Biondi M, Fusar-Poli P. Poster #S53 MEDIAL FRONTAL GYRUS ALTERATIONS IN SCHIZOPHRENIA: RELATIONSHIP WITH DURATION OF ILLNESS AND EXECUTIVE DYSFUNCTION Schizophrenia Research. 153. DOI: 10.1016/S0920-9964(14)70332-9  0.313
2014 Fusar-Poli P, Borgwardt S, Bechdolf A, Addington J, Riecher-Rössler A, Schultze-Lutter F, Keshavan M, Wood S, Ruhrmann S, Seidman LI, Valmaggia L, Cannon T, Velthorst E, Haan Ld, Cornblatt B, et al. The Psychosis High Risk State: Is It Valid? Schizophrenia Research. 153. DOI: 10.1016/S0920-9964(14)70075-1  0.366
2013 Tourjman V, Kouassi É, Koué MÈ, Rocchetti M, Fortin-Fournier S, Fusar-Poli P, Potvin S. Antipsychotics' effects on blood levels of cytokines in schizophrenia: a meta-analysis. Schizophrenia Research. 151: 43-7. PMID 24200418 DOI: 10.1016/J.Schres.2013.10.011  0.314
2013 Rocchetti M, Crescini A, Borgwardt S, Caverzasi E, Politi P, Atakan Z, Fusar-Poli P. Is cannabis neurotoxic for the healthy brain? A meta-analytical review of structural brain alterations in non-psychotic users. Psychiatry and Clinical Neurosciences. 67: 483-92. PMID 24118193 DOI: 10.1111/Pcn.12085  0.305
2013 David SP, Ware JJ, Chu IM, Loftus PD, Fusar-Poli P, Radua J, Munafò MR, Ioannidis JP. Potential reporting bias in fMRI studies of the brain. Plos One. 8: e70104. PMID 23936149 DOI: 10.1371/Journal.Pone.0070104  0.492
2013 Simon AE, Borgwardt S, Riecher-Rössler A, Velthorst E, de Haan L, Fusar-Poli P. Moving beyond transition outcomes: meta-analysis of remission rates in individuals at high clinical risk for psychosis. Psychiatry Research. 209: 266-72. PMID 23871169 DOI: 10.1016/J.Psychres.2013.03.004  0.44
2013 Schmidt A, Smieskova R, Aston J, Simon A, Allen P, Fusar-Poli P, McGuire PK, Riecher-Rössler A, Stephan KE, Borgwardt S. Brain connectivity abnormalities predating the onset of psychosis: correlation with the effect of medication. Jama Psychiatry. 70: 903-12. PMID 23824230 DOI: 10.1001/Jamapsychiatry.2013.117  0.495
2013 Fusar-Poli P, Smieskova R, Kempton MJ, Ho BC, Andreasen NC, Borgwardt S. Progressive brain changes in schizophrenia related to antipsychotic treatment? A meta-analysis of longitudinal MRI studies. Neuroscience and Biobehavioral Reviews. 37: 1680-91. PMID 23769814 DOI: 10.1016/J.Neubiorev.2013.06.001  0.346
2013 Pompili M, Serafini G, Innamorati M, Venturini P, Fusar-Poli P, Sher L, Amore M, Girardi P. Agomelatine, a novel intriguing antidepressant option enhancing neuroplasticity: a critical review. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 14: 412-31. PMID 23530731 DOI: 10.3109/15622975.2013.765593  0.315
2013 Chew LJ, Fusar-Poli P, Schmitz T. Oligodendroglial alterations and the role of microglia in white matter injury: relevance to schizophrenia. Developmental Neuroscience. 35: 102-29. PMID 23446060 DOI: 10.1159/000346157  0.344
2013 Valmaggia LR, Stahl D, Yung AR, Nelson B, Fusar-Poli P, McGorry PD, McGuire PK. Negative psychotic symptoms and impaired role functioning predict transition outcomes in the at-risk mental state: a latent class cluster analysis study. Psychological Medicine. 43: 2311-25. PMID 23442767 DOI: 10.1017/S0033291713000251  0.511
2013 Mishara AL, Fusar-Poli P. The phenomenology and neurobiology of delusion formation during psychosis onset: Jaspers, Truman symptoms, and aberrant salience. Schizophrenia Bulletin. 39: 278-86. PMID 23354468 DOI: 10.1093/Schbul/Sbs155  0.334
2013 Emsley R, Chiliza B, Asmal L, Mashile M, Fusar-Poli P. Long-acting injectable antipsychotics in early psychosis: a literature review. Early Intervention in Psychiatry. 7: 247-54. PMID 23342964 DOI: 10.1111/Eip.12027  0.31
2013 Fusar-Poli P. One century of Allgemeine Psychopathologie (1913 to 2013) by Karl Jaspers. Schizophrenia Bulletin. 39: 268-9. PMID 23287616 DOI: 10.1093/Schbul/Sbs158  0.338
2013 Johnsen E, Hugdahl K, Fusar-Poli P, Kroken RA, Kompus K. Neuropsychopharmacology of auditory hallucinations: insights from pharmacological functional MRI and perspectives for future research. Expert Review of Neurotherapeutics. 13: 23-36. PMID 23253389 DOI: 10.1586/Ern.12.147  0.337
2013 Fusar-Poli P, Borgwardt S, Bechdolf A, Addington J, Riecher-Rössler A, Schultze-Lutter F, Keshavan M, Wood S, Ruhrmann S, Seidman LJ, Valmaggia L, Cannon T, Velthorst E, De Haan L, Cornblatt B, et al. The psychosis high-risk state: a comprehensive state-of-the-art review. Jama Psychiatry. 70: 107-20. PMID 23165428 DOI: 10.1001/Jamapsychiatry.2013.269  0.52
2013 Fusar-Poli P, Kempton MJ, Rosenheck RA. Efficacy and safety of second-generation long-acting injections in schizophrenia: a meta-analysis of randomized-controlled trials. International Clinical Psychopharmacology. 28: 57-66. PMID 23165366 DOI: 10.1097/Yic.0B013E32835B091F  0.362
2013 Radua J, Romeo M, Mataix-Cols D, Fusar-Poli P. A general approach for combining voxel-based meta-analyses conducted in different neuroimaging modalities. Current Medicinal Chemistry. 20: 462-6. PMID 23157638 DOI: 10.2174/0929867311320030017  0.622
2013 Fusar-Poli P, Byrne M, Badger S, Valmaggia LR, McGuire PK. Outreach and support in south London (OASIS), 2001-2011: ten years of early diagnosis and treatment for young individuals at high clinical risk for psychosis. European Psychiatry : the Journal of the Association of European Psychiatrists. 28: 315-26. PMID 23137782 DOI: 10.1016/J.Eurpsy.2012.08.002  0.518
2013 Atakan Z, Bhattacharyya S, Allen P, Martín-Santos R, Crippa JA, Borgwardt SJ, Fusar-Poli P, Seal M, Sallis H, Stahl D, Zuardi AW, Rubia K, McGuire P. Cannabis affects people differently: inter-subject variation in the psychotogenic effects of Δ9-tetrahydrocannabinol: a functional magnetic resonance imaging study with healthy volunteers. Psychological Medicine. 43: 1255-67. PMID 23020923 DOI: 10.1017/S0033291712001924  0.446
2013 Malchow B, Hasan A, Fusar-Poli P, Schmitt A, Falkai P, Wobrock T. Cannabis abuse and brain morphology in schizophrenia: a review of the available evidence. European Archives of Psychiatry and Clinical Neuroscience. 263: 3-13. PMID 22907121 DOI: 10.1007/S00406-012-0346-3  0.367
2013 Fusar-Poli P, Bechdolf A, Taylor MJ, Bonoldi I, Carpenter WT, Yung AR, McGuire P. At risk for schizophrenic or affective psychoses? A meta-analysis of DSM/ICD diagnostic outcomes in individuals at high clinical risk. Schizophrenia Bulletin. 39: 923-32. PMID 22589370 DOI: 10.1093/Schbul/Sbs060  0.559
2013 Fusar-Poli P, Meyer-Lindenberg A. Striatal presynaptic dopamine in schizophrenia, Part I: meta-analysis of dopamine active transporter (DAT) density. Schizophrenia Bulletin. 39: 22-32. PMID 22282456 DOI: 10.1093/Schbul/Sbr111  0.306
2013 Fusar-Poli P, Meyer-Lindenberg A. Striatal presynaptic dopamine in schizophrenia, part II: meta-analysis of [(18)F/(11)C]-DOPA PET studies. Schizophrenia Bulletin. 39: 33-42. PMID 22282454 DOI: 10.1093/Schbul/Sbr180  0.344
2012 Lord LD, Allen P, Expert P, Howes O, Broome M, Lambiotte R, Fusar-Poli P, Valli I, McGuire P, Turkheimer FE. Functional brain networks before the onset of psychosis: A prospective fMRI study with graph theoretical analysis. Neuroimage. Clinical. 1: 91-8. PMID 24179741 DOI: 10.1016/J.Nicl.2012.09.008  0.502
2012 Jung WH, Borgwardt S, Fusar-Poli P, Kwon JS. Gray matter volumetric abnormalities associated with the onset of psychosis. Frontiers in Psychiatry. 3: 101. PMID 23227013 DOI: 10.3389/Fpsyt.2012.00101  0.389
2012 Keilhoff G, Fusar-Poli P, Becker A. Effects of antipsychotics on dentate gyrus stem cell proliferation and survival in animal models: a critical update. Neural Plasticity. 2012: 832757. PMID 23150836 DOI: 10.1155/2012/832757  0.325
2012 Yung AR, Woods SW, Ruhrmann S, Addington J, Schultze-Lutter F, Cornblatt BA, Amminger GP, Bechdolf A, Birchwood M, Borgwardt S, Cannon TD, de Haan L, French P, Fusar-Poli P, Keshavan M, et al. Whither the attenuated psychosis syndrome? Schizophrenia Bulletin. 38: 1130-4. PMID 23144056 DOI: 10.1093/Schbul/Sbs108  0.559
2012 Borgwardt S, Fusar-Poli P. White matter pathology--an endophenotype for bipolar disorder? Bmc Psychiatry. 12: 138. PMID 22970986 DOI: 10.1186/1471-244X-12-138  0.384
2012 Inta D, Lima-Ojeda JM, Gass P, Fusar-Poli P. Postnatal neurogenesis and dopamine alterations in early psychosis. Recent Patents On Cns Drug Discovery. 7: 236-42. PMID 22963280 DOI: 10.2174/157488912803251998  0.342
2012 Schultz CC, Fusar-Poli P, Wagner G, Koch K, Schachtzabel C, Gruber O, Sauer H, Schlösser RG. Multimodal functional and structural imaging investigations in psychosis research. European Archives of Psychiatry and Clinical Neuroscience. 262: S97-106. PMID 22940744 DOI: 10.1007/S00406-012-0360-5  0.323
2012 Borgwardt S, Radua J, Mechelli A, Fusar-Poli P. Why are psychiatric imaging methods clinically unreliable? Conclusions and practical guidelines for authors, editors and reviewers. Behavioral and Brain Functions : Bbf. 8: 46. PMID 22938624 DOI: 10.1186/1744-9081-8-46  0.516
2012 Radua J, Borgwardt S, Crescini A, Mataix-Cols D, Meyer-Lindenberg A, McGuire PK, Fusar-Poli P. Multimodal meta-analysis of structural and functional brain changes in first episode psychosis and the effects of antipsychotic medication. Neuroscience and Biobehavioral Reviews. 36: 2325-33. PMID 22910680 DOI: 10.1016/J.Neubiorev.2012.07.012  0.668
2012 Fusar-Poli P, Deste G, Smieskova R, Barlati S, Yung AR, Howes O, Stieglitz RD, Vita A, McGuire P, Borgwardt S. Cognitive functioning in prodromal psychosis: a meta-analysis. Archives of General Psychiatry. 69: 562-71. PMID 22664547 DOI: 10.1001/Archgenpsychiatry.2011.1592  0.471
2012 Borgwardt S, Fusar-Poli P. Third-generation neuroimaging in early schizophrenia: translating research evidence into clinical utility. The British Journal of Psychiatry : the Journal of Mental Science. 200: 270-2. PMID 22474231 DOI: 10.1192/Bjp.Bp.111.103234  0.35
2012 Fusar-Poli P, Bonoldi I, Yung AR, Borgwardt S, Kempton MJ, Valmaggia L, Barale F, Caverzasi E, McGuire P. Predicting psychosis: meta-analysis of transition outcomes in individuals at high clinical risk. Archives of General Psychiatry. 69: 220-9. PMID 22393215 DOI: 10.1001/Archgenpsychiatry.2011.1472  0.536
2012 Fusar-Poli P. Predicting the development of schizophrenia. The British Journal of Psychiatry : the Journal of Mental Science. 200: 254-5; author reply . PMID 22383768 DOI: 10.1192/Bjp.200.3.254A  0.346
2012 Fusar-Poli P, Berger G. Eicosapentaenoic acid interventions in schizophrenia: meta-analysis of randomized, placebo-controlled studies. Journal of Clinical Psychopharmacology. 32: 179-85. PMID 22367656 DOI: 10.1097/Jcp.0B013E318248B7Bb  0.303
2012 Fusar-Poli P, Howes O, Bechdolf A, Borgwardt S. Mapping vulnerability to bipolar disorder: a systematic review and meta-analysis of neuroimaging studies. Journal of Psychiatry & Neuroscience : Jpn. 37: 170-84. PMID 22297067 DOI: 10.1503/Jpn.110061  0.433
2012 Allen P, Luigjes J, Howes OD, Egerton A, Hirao K, Valli I, Kambeitz J, Fusar-Poli P, Broome M, McGuire P. Transition to psychosis associated with prefrontal and subcortical dysfunction in ultra high-risk individuals. Schizophrenia Bulletin. 38: 1268-76. PMID 22290265 DOI: 10.1093/Schbul/Sbr194  0.532
2012 Singh F, Mirzakhanian H, Fusar-Poli P, de la Fuente-Sandoval C, Cadenhead KS. Ethical implications for clinical practice and future research in "at risk" individuals. Current Pharmaceutical Design. 18: 606-12. PMID 22239594 DOI: 10.2174/138161212799316262  0.451
2012 Broome M, Fusar-Poli P. Philosophical issues in the prodromal phase of psychosis. Current Pharmaceutical Design. 18: 596-605. PMID 22239593 DOI: 10.2174/138161212799316190  0.403
2012 Valmaggia LR, McGuire PK, Fusar-Poli P, Howes O, McCrone P. Economic impact of early detection and early intervention of psychosis. Current Pharmaceutical Design. 18: 592-5. PMID 22239592 DOI: 10.2174/138161212799316145  0.418
2012 Mossaheb N, Schloegelhofer M, Schaefer MR, Fusar-Poli P, Smesny S, McGorry P, Berger G, Amminger GP. Polyunsaturated fatty acids in emerging psychosis. Current Pharmaceutical Design. 18: 576-91. PMID 22239591 DOI: 10.2174/138161212799316055  0.318
2012 Kolliakou A, Fusar-Poli P, Atakan Z. Cannabis abuse and vulnerability to psychosis: targeting preventive services. Current Pharmaceutical Design. 18: 542-9. PMID 22239586 DOI: 10.2174/138161212799316208  0.313
2012 Barlati S, De Peri L, Deste G, Fusar-Poli P, Vita A. Cognitive remediation in the early course of schizophrenia: a critical review. Current Pharmaceutical Design. 18: 534-41. PMID 22239585 DOI: 10.2174/138161212799316091  0.315
2012 Bourque F, van der Ven E, Fusar-Poli P, Malla A. Immigration, social environment and onset of psychotic disorders. Current Pharmaceutical Design. 18: 518-26. PMID 22239583 DOI: 10.2174/138161212799316028  0.39
2012 Mechelli A, Fusar-Poli P, Prata D, Papagni SA, Tognin S, Kambeitz J, Fu C, Picchioni M, Walshe M, Toulopoulou T, Bramon E, Murray R, McGuire P. Genetic vulnerability to psychosis and cortical function: epistatic effects between DAAO and G72. Current Pharmaceutical Design. 18: 510-7. PMID 22239582 DOI: 10.2174/138161212799316037  0.405
2012 Emanuele E, Martinelli V, Abbiati V, Fusar-Poli P, Politi P. Biochemical markers of impending psychosis. Current Pharmaceutical Design. 18: 505-9. PMID 22239581 DOI: 10.2174/138161212799316000  0.392
2012 Röthlisberger M, Riecher-Rössler A, Aston J, Fusar-Poli P, Radü EW, Borgwardt S. Cingulate volume abnormalities in emerging psychosis. Current Pharmaceutical Design. 18: 495-504. PMID 22239580 DOI: 10.2174/138161212799316316  0.361
2012 De Peri L, Crescini A, Deste G, Fusar-Poli P, Sacchetti E, Vita A. Brain structural abnormalities at the onset of schizophrenia and bipolar disorder: a meta-analysis of controlled magnetic resonance imaging studies. Current Pharmaceutical Design. 18: 486-94. PMID 22239579 DOI: 10.2174/138161212799316253  0.353
2012 Crossley NA, Constante M, Fusar-Poli P, Bramon E. Neurophysiological alterations in the prepsychotic phases. Current Pharmaceutical Design. 18: 479-85. PMID 22239578 DOI: 10.2174/138161212799316307  0.391
2012 Egerton A, Fusar-Poli P, Stone JM. Glutamate and psychosis risk. Current Pharmaceutical Design. 18: 466-78. PMID 22239577 DOI: 10.2174/138161212799316244  0.408
2012 Howes OD, Fusar-Poli P, Bloomfield M, Selvaraj S, McGuire P. From the prodrome to chronic schizophrenia: the neurobiology underlying psychotic symptoms and cognitive impairments. Current Pharmaceutical Design. 18: 459-65. PMID 22239576 DOI: 10.2174/138161212799316217  0.474
2012 Valli I, Tognin S, Fusar-Poli P, Mechelli A. Episodic memory dysfunction in individuals at high-risk of psychosis: a systematic review of neuropsychological and neurofunctional studies. Current Pharmaceutical Design. 18: 443-58. PMID 22239575 DOI: 10.2174/138161212799316271  0.383
2012 Karlsgodt KH, Jacobson SC, Seal M, Fusar-Poli P. The relationship of developmental changes in white matter to the onset of psychosis. Current Pharmaceutical Design. 18: 422-33. PMID 22239573 DOI: 10.2174/138161212799316073  0.322
2012 Smieskova R, Fusar-Poli P, Riecher-Rössler A, Borgwardt S. Neuroimaging and resilience factors--staging of the at-risk mental state? Current Pharmaceutical Design. 18: 416-21. PMID 22239572 DOI: 10.2174/138161212799316046  0.449
2012 Fusar-Poli P, Hobson R, Raduelli M, Balottin U. Reliability and validity of the Comprehensive Assessment of the At Risk Mental State, Italian version (CAARMS-I). Current Pharmaceutical Design. 18: 386-91. PMID 22239569 DOI: 10.2174/138161212799316118  0.353
2012 Nelson B, Fusar-Poli P, Yung AR. Can we detect psychotic-like experiences in the general population? Current Pharmaceutical Design. 18: 376-85. PMID 22239568 DOI: 10.2174/138161212799316136  0.416
2012 Schultze-Lutter F, Ruhrmann S, Fusar-Poli P, Bechdolf A, Schimmelmann BG, Klosterkötter J. Basic symptoms and the prediction of first-episode psychosis. Current Pharmaceutical Design. 18: 351-7. PMID 22239566 DOI: 10.2174/138161212799316064  0.398
2012 Yung AR, Fusar-Poli P, Nelson B. The ultra high risk approach to define psychosis risk. Current Pharmaceutical Design. 18: 346-50. PMID 22239565 DOI: 10.2174/138161212799316299  0.453
2012 Stanghellini G, Fusar-Poli P. The vulnerability to schizophrenia mainstream research paradigms and phenomenological directions. Current Pharmaceutical Design. 18: 338-45. PMID 22239564 DOI: 10.2174/138161212799316109  0.355
2012 Masillo A, Day F, Laing J, Howes O, Fusar-Poli P, Byrne M, Bhattacharyya S, Fiori Nastro P, Girardi P, McGuire PK, Valmaggia LR. Interpersonal sensitivity in the at-risk mental state for psychosis. Psychological Medicine. 42: 1835-45. PMID 22225783 DOI: 10.1017/S0033291711002996  0.484
2012 Bhattacharyya S, Crippa JA, Allen P, Martin-Santos R, Borgwardt S, Fusar-Poli P, Rubia K, Kambeitz J, O'Carroll C, Seal ML, Giampietro V, Brammer M, Zuardi AW, Atakan Z, McGuire PK. Induction of psychosis by Δ9-tetrahydrocannabinol reflects modulation of prefrontal and striatal function during attentional salience processing. Archives of General Psychiatry. 69: 27-36. PMID 22213786 DOI: 10.1001/Archgenpsychiatry.2011.161  0.487
2012 Fusar-Poli P. Voxel-wise meta-analysis of fMRI studies in patients at clinical high risk for psychosis. Journal of Psychiatry & Neuroscience : Jpn. 37: 106-12. PMID 22146150 DOI: 10.1503/Jpn.110021  0.423
2012 Smieskova R, Fusar-Poli P, Aston J, Simon A, Bendfeldt K, Lenz C, Stieglitz RD, McGuire P, Riecher-Rössler A, Borgwardt SJ. Insular volume abnormalities associated with different transition probabilities to psychosis. Psychological Medicine. 42: 1613-25. PMID 22126702 DOI: 10.1017/S0033291711002716  0.502
2012 Fusar-Poli P, Radua J, McGuire P, Borgwardt S. Neuroanatomical maps of psychosis onset: voxel-wise meta-analysis of antipsychotic-naive VBM studies. Schizophrenia Bulletin. 38: 1297-307. PMID 22080494 DOI: 10.1093/Schbul/Sbr134  0.655
2012 Shaikh M, Valmaggia L, Broome MR, Dutt A, Lappin J, Day F, Woolley J, Tabraham P, Walshe M, Johns L, Fusar-Poli P, Howes O, Murray RM, McGuire P, Bramon E. Reduced mismatch negativity predates the onset of psychosis. Schizophrenia Research. 134: 42-8. PMID 22024244 DOI: 10.1016/J.Schres.2011.09.022  0.542
2012 Fusar-Poli P, McGuire P, Borgwardt S. Mapping prodromal psychosis: a critical review of neuroimaging studies. European Psychiatry : the Journal of the Association of European Psychiatrists. 27: 181-91. PMID 21940151 DOI: 10.1016/J.Eurpsy.2011.06.006  0.525
2012 Allen P, Chaddock CA, Howes OD, Egerton A, Seal ML, Fusar-Poli P, Valli I, Day F, McGuire PK. Abnormal relationship between medial temporal lobe and subcortical dopamine function in people with an ultra high risk for psychosis. Schizophrenia Bulletin. 38: 1040-9. PMID 21536784 DOI: 10.1093/Schbul/Sbr017  0.473
2012 Meer FJvd, Veithorst E, Meijer CJ, Machielsen MW, Fusar-Poli P, Haan L. Poster #184 CANNABIS USE IN PATIENTS AT CLINICAL HIGH RISK OF PSYCHOSIS: IMPACT ON PRODROMAL SYMPTOMS AND TRANSITION TO PSYCHOSIS – A SYSTEMATIC REVIEW Schizophrenia Research. 136. DOI: 10.1016/S0920-9964(12)71016-2  0.394
2012 McGuire P, Howes O, Stone J, Egerton A, Tognin S, Fusar-Poli P, Borgwardt S, Allen P, Valli I, Barker G, Roiser J, Chaddock C, Mechelli A. ALTERATIONS IN BRAIN STRUCTURE, FUNCTION AND CHEMISTRY PRIOR TO THE ONSET OF PSYCHOSIS Schizophrenia Research. 136: S55. DOI: 10.1016/S0920-9964(12)70200-1  0.42
2012 Bhattacharyya S, Crippa I, Martin-Santos R, Allen P, Borgwardt S, Fusar-Poli P, Seal M, Zuardi A, Atakan Z, McGuire P. THE EFFECTS OF DELTA-9-TETRAHYDROCANNABINOL AND CANNABIDIOL ON BRAIN FUNCTION IN MAN Schizophrenia Research. 136: S26. DOI: 10.1016/S0920-9964(12)70091-9  0.39
2011 Borgwardt S, McGuire P, Fusar-Poli P. Gray matters!--mapping the transition to psychosis. Schizophrenia Research. 133: 63-7. PMID 21943556 DOI: 10.1016/J.Schres.2011.08.021  0.496
2011 Fusar-Poli P, Stone JM, Broome MR, Valli I, Mechelli A, McLean MA, Lythgoe DJ, O'Gorman RL, Barker GJ, McGuire PK. Thalamic glutamate levels as a predictor of cortical response during executive functioning in subjects at high risk for psychosis Archives of General Psychiatry. 68: 881-890. PMID 21536967 DOI: 10.1001/Archgenpsychiatry.2011.46  0.478
2011 Winton-Brown TT, Allen P, Bhattacharyya S, Bhattacharrya S, Borgwardt SJ, Fusar-Poli P, Crippa JA, Seal ML, Martin-Santos R, Ffytche D, Zuardi AW, Atakan Z, McGuire PK. Modulation of auditory and visual processing by delta-9-tetrahydrocannabinol and cannabidiol: an FMRI study. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 36: 1340-8. PMID 21412224 DOI: 10.1038/Npp.2011.17  0.435
2011 Fusar-Poli P, Crossley N, Woolley J, Carletti F, Perez-Iglesias R, Broome M, Johns L, Tabraham P, Bramon E, McGuire P. White matter alterations related to P300 abnormalities in individuals at high risk for psychosis: an MRI-EEG study. Journal of Psychiatry & Neuroscience : Jpn. 36: 239-48. PMID 21299920 DOI: 10.1503/Jpn.100083  0.475
2011 Fusar-Poli P, Borgwardt S, Crescini A, Deste G, Kempton MJ, Lawrie S, Mc Guire P, Sacchetti E. Neuroanatomy of vulnerability to psychosis: a voxel-based meta-analysis. Neuroscience and Biobehavioral Reviews. 35: 1175-85. PMID 21168439 DOI: 10.1016/J.Neubiorev.2010.12.005  0.373
2011 Fusar-Poli P, Crossley N, Woolley J, Carletti F, Perez-Iglesias R, Broome M, Johns L, Tabraham P, Bramon E, McGuire P. Gray matter alterations related to P300 abnormalities in subjects at high risk for psychosis: longitudinal MRI-EEG study. Neuroimage. 55: 320-8. PMID 21129489 DOI: 10.1016/J.Neuroimage.2010.11.075  0.483
2011 Valli I, Stone J, Mechelli A, Bhattacharyya S, Raffin M, Allen P, Fusar-Poli P, Lythgoe D, O'Gorman R, Seal M, McGuire P. Altered medial temporal activation related to local glutamate levels in subjects with prodromal signs of psychosis Biological Psychiatry. 69: 97-99. PMID 21035785 DOI: 10.1016/J.Biopsych.2010.08.033  0.44
2011 Crippa JA, Derenusson GN, Ferrari TB, Wichert-Ana L, Duran FL, Martin-Santos R, Simões MV, Bhattacharyya S, Fusar-Poli P, Atakan Z, Santos Filho A, Freitas-Ferrari MC, McGuire PK, Zuardi AW, Busatto GF, et al. Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report. Journal of Psychopharmacology (Oxford, England). 25: 121-30. PMID 20829306 DOI: 10.1177/0269881110379283  0.456
2011 Najt P, Fusar-Poli P, Brambilla P. Co-occurring mental and substance abuse disorders: A review on the potential predictors and clinical outcomes Psychiatry Research. 186: 159-164. PMID 20728943 DOI: 10.1016/J.Psychres.2010.07.042  0.327
2011 Serafini G, Pompili M, Innamorati M, Fusar-Poli P, Akiskal HS, Rihmer Z, Lester D, Romano A, De Oliveira IR, Strusi L, Ferracuti S, Girardi P, Tatarelli R. Affective temperamental profiles are associated with white matter hyperintensity and suicidal risk in patients with mood disorders Journal of Affective Disorders. 129: 47-55. PMID 20708276 DOI: 10.1016/J.Jad.2010.07.020  0.356
2011 Fusar-Poli P, Broome MR, Woolley JB, Johns LC, Tabraham P, Bramon E, Valmaggia L, Williams SC, McGuire P. Altered brain function directly related to structural abnormalities in people at ultra high risk of psychosis: longitudinal VBM-fMRI study. Journal of Psychiatric Research. 45: 190-8. PMID 20580022 DOI: 10.1016/J.Jpsychires.2010.05.012  0.5
2011 Fusar-Poli P, Howes OD, Allen P, Broome M, Valli I, Asselin MC, Montgomery AJ, Grasby PM, McGuire P. Abnormal prefrontal activation directly related to pre-synaptic striatal dopamine dysfunction in people at clinical high risk for psychosis. Molecular Psychiatry. 16: 67-75. PMID 19949389 DOI: 10.1038/Mp.2009.108  0.506
2011 Allen P, Seal ML, Valli I, Fusar-Poli P, Perlini C, Day F, Wood SJ, Williams SC, McGuire PK. Altered prefrontal and hippocampal function during verbal encoding and recognition in people with prodromal symptoms of psychosis Schizophrenia Bulletin. 37: 746-756. PMID 19933712 DOI: 10.1093/Schbul/Sbp113  0.479
2011 Fusar-Poli P, Broome MR, Matthiasson P, Woolley JB, Mechelli A, Johns LC, Tabraham P, Bramon E, Valmaggia L, Williams SC, McGuire P. Prefrontal function at presentation directly related to clinical outcome in people at ultrahigh risk of psychosis. Schizophrenia Bulletin. 37: 189-98. PMID 19666832 DOI: 10.1093/Schbul/Sbp074  0.501
2011 Crossley N, Mechelli A, Fusar-Poli P, Broome M, Matthiasson P, Johns L, Bramon E, Valmaggia L, Williams S, McGuire P. Superior temporal lobe dysfunction and frontotemporal dysconnectivity in subjects at risk of psychosis and in first-episode psychosis International Clinical Psychopharmacology. 26: e117-e118. DOI: 10.1097/01.Yic.0000405832.08668.7A  0.512
2011 Winton-Brown TT, Allen P, Bhattacharrya S, Borgwardt SJ, Fusar-Poli P, Crippa JA, Seal ML, Martin-Santos R, Ffytche D, Zuardi AW, Atakan Z, McGuire PK. Erratum: Modulation of Auditory and Visual Processing by Delta-9-Tetrahydrocannabinol and Cannabidiol: an fMRI Study Neuropsychopharmacology. 36: 1778-1778. DOI: 10.1038/Npp.2011.58  0.368
2010 Fusar-Poli P, Broome MR, Matthiasson P, Woolley JB, Johns LC, Tabraham P, Bramon E, Valmaggia L, Williams SC, McGuire P. Spatial working memory in individuals at high risk for psychosis: longitudinal fMRI study. Schizophrenia Research. 123: 45-52. PMID 20688479 DOI: 10.1016/J.Schres.2010.06.008  0.495
2010 Fusar-Poli P, Howes OD, Allen P, Broome M, Valli I, Asselin MC, Grasby PM, McGuire PK. Abnormal frontostriatal interactions in people with prodromal signs of psychosis: a multimodal imaging study. Archives of General Psychiatry. 67: 683-91. PMID 20603449 DOI: 10.1001/Archgenpsychiatry.2010.77  0.468
2010 Broome MR, Fusar-Poli P, Matthiasson P, Woolley JB, Valmaggia L, Johns LC, Tabraham P, Bramon E, Williams SC, Brammer MJ, Chitnis X, Zelaya F, McGuire PK. Neural correlates of visuospatial working memory in the 'at-risk mental state'. Psychological Medicine. 40: 1987-99. PMID 20214840 DOI: 10.1017/S0033291710000280  0.481
2010 Smieskova R, Fusar-Poli P, Allen P, Bendfeldt K, Stieglitz RD, Drewe J, Radue EW, McGuire PK, Riecher-Rössler A, Borgwardt SJ. Neuroimaging predictors of transition to psychosis-A systematic review and meta-analysis Neuroscience and Biobehavioral Reviews. 34: 1207-1222. PMID 20144653 DOI: 10.1016/J.Neubiorev.2010.01.016  0.334
2010 Fusar-Poli P, Bhattacharyya S, Allen P, Crippa JA, Borgwardt S, Martin-Santos R, Seal M, O'Carroll C, Atakan Z, Zuardi AW, McGuire P. Effect of image analysis software on neurofunctional activation during processing of emotional human faces. Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia. 17: 311-4. PMID 20079652 DOI: 10.1016/J.Jocn.2009.06.027  0.43
2010 Broome MR, Matthiasson P, Fusar-Poli P, Woolley JB, Johns LC, Tabraham P, Bramon E, Valmaggia L, Williams SC, Brammer MJ, Chitnis X, McGuire PK. Neural correlates of movement generation in the 'at-risk mental state'. Acta Psychiatrica Scandinavica. 122: 295-301. PMID 20064129 DOI: 10.1111/J.1600-0447.2009.01524.X  0.504
2010 Bhattacharyya S, Morrison PD, Fusar-Poli P, Martin-Santos R, Borgwardt S, Winton-Brown T, Nosarti C, O' Carroll CM, Seal M, Allen P, Mehta MA, Stone JM, Tunstall N, Giampietro V, Kapur S, et al. Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 35: 764-74. PMID 19924114 DOI: 10.1038/Npp.2009.184  0.45
2010 Fusar-Poli P, Byrne M, Valmaggia L, Day F, Tabraham P, Johns L, McGuire P. Social dysfunction predicts two years clinical outcome in people at ultra high risk for psychosis. Journal of Psychiatric Research. 44: 294-301. PMID 19836755 DOI: 10.1016/J.Jpsychires.2009.08.016  0.54
2010 Fusar-Poli P, Allen P, Bhattacharyya S, Crippa JA, Mechelli A, Borgwardt S, Martin-Santos R, Seal ML, O'Carrol C, Atakan Z, Zuardi AW, McGuire P. Modulation of effective connectivity during emotional processing by Delta 9-tetrahydrocannabinol and cannabidiol. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 13: 421-32. PMID 19775500 DOI: 10.1017/S1461145709990617  0.431
2010 Mechelli A, Viding E, Kumar A, Pettersson-Yeo W, Fusar-Poli P, Tognin S, O'Donovan MC, McGuire P. Dysbindin modulates brain function during visual processing in children. Neuroimage. 49: 817-22. PMID 19631276 DOI: 10.1016/J.Neuroimage.2009.07.030  0.485
2010 Martín-Santos R, Fagundo AB, Crippa JA, Atakan Z, Bhattacharyya S, Allen P, Fusar-Poli P, Borgwardt S, Seal M, Busatto GF, McGuire P. Neuroimaging in cannabis use: a systematic review of the literature Psychological Medicine. 40: 383-398. PMID 19627647 DOI: 10.1017/S0033291709990729  0.434
2010 Atakan Z, Bhattacharyya S, Allen P, Borgwardt S, Fusar-Poli P, Martin-Santos R, Crippa JA, Seal M, Kambeitz JP, Andiappan M, Stahl D, Zuardi AW, McGuire P. Why Does Cannabis Effect People Differently? Comparing Those With Temporary Psychotic Symptoms Vs. Those With No Psychotic Symptoms Following The Oral Administration Of Δ-9-Tetrahydrocannabinol – A Functional Mri Study Schizophrenia Research. 117: 233-233. DOI: 10.1016/J.Schres.2010.02.346  0.446
2010 Allen P, Chaddock C, Howes OD, Fusar-Poli P, Egerton A, McGuire P. ALTERED ASSOCIATION BETWEEN HIPPOCAMPAL ACTIVATION DURING EPISODIC ENCODING AND STRIATAL DOPAMINE FUNCTION IN PEOPLE WITH PRODROMAL SYMPTOMS OF PSYCHOSIS Schizophrenia Research. 117: 231. DOI: 10.1016/J.Schres.2010.02.342  0.432
2010 Fusar-Poli P. Abnormal Prefrontal Activation Related To Striatal Dopamine Dysfunction In People At Clinical Risk For Psychosis Schizophrenia Research. 117: 169-169. DOI: 10.1016/J.Schres.2010.02.194  0.35
2009 Fusar-Poli P, Placentino A, Carletti F, Landi P, Allen P, Surguladze S, Benedetti F, Abbamonte M, Gasparotti R, Barale F, Perez J, McGuire P, Politi P. Functional atlas of emotional faces processing: a voxel-based meta-analysis of 105 functional magnetic resonance imaging studies. Journal of Psychiatry & Neuroscience : Jpn. 34: 418-32. PMID 19949718  0.61
2009 Crippa JA, Zuardi AW, Martín-Santos R, Bhattacharyya S, Atakan Z, McGuire P, Fusar-Poli P. Cannabis and anxiety: a critical review of the evidence. Human Psychopharmacology. 24: 515-23. PMID 19693792 DOI: 10.1002/Hup.1048  0.427
2009 Bhattacharyya S, Crippa JA, Martin-Santos R, Winton-Brown T, Fusar-Poli P. Imaging the neural effects of cannabinoids: Current status and future opportunities for psychopharmacology Current Pharmaceutical Design. 15: 2603-2614. PMID 19689331 DOI: 10.2174/138161209788957465  0.359
2009 Smieskova R, Fusar-Poli P, Allen P, Bendfeldt K, Stieglitz RD, Drewe J, Radue EW, McGuire PK, Riecher-Rössler A, Borgwardt SJ. The effects of antipsychotics on the brain: What have we learnt from structural imaging of schizophrenia? - A systematic review Current Pharmaceutical Design. 15: 2535-2549. PMID 19689326 DOI: 10.2174/138161209788957456  0.465
2009 Fusar-Poli P, Howes OD, McGuire P. Pseudohallucinations versus true hallucinations in prodromal psychosis: does it really matter? The Journal of Clinical Psychiatry. 70: 1056-7. PMID 19653984 DOI: 10.4088/Jcp.08L04848  0.449
2009 Borgwardt SJ, Riecher-Rössler A, Smieskova R, McGuire PK, Fusar-Poli P. Superior temporal gray and white matter changes in schizophrenia or antipsychotic related effects? Schizophrenia Research. 113: 109-110. PMID 19559570 DOI: 10.1016/J.Schres.2009.05.028  0.433
2009 Crossley NA, Mechelli A, Fusar-Poli P, Broome MR, Matthiasson P, Johns LC, Bramon E, Valmaggia L, Williams SC, McGuire PK. Superior temporal lobe dysfunction and frontotemporal dysconnectivity in subjects at risk of psychosis and in first-episode psychosis. Human Brain Mapping. 30: 4129-37. PMID 19530219 DOI: 10.1002/Hbm.20834  0.501
2009 Borgwardt SJ, Smieskova R, Fusar-Poli P, Bendfeldt K, Riecher-Rössler A. The effects of antipsychotics on brain structure: What have we learnt from structural imaging of schizophrenia? Psychological Medicine. 39: 1781-1782. PMID 19476691 DOI: 10.1017/S0033291709006060  0.322
2009 Fusar-Poli P, De Marco L, Cavallin F, Bertorello A, Nicolasi M, Politi P. Lifestyles and cardiovascular risk in individuals with functional psychoses Perspectives in Psychiatric Care. 45: 87-99. PMID 19366419 DOI: 10.1111/J.1744-6163.2009.00202.X  0.368
2009 Bhattacharyya S, Fusar-Poli P, Borgwardt S, Martin-Santos R, Nosarti C, O'Carroll C, Allen P, Seal ML, Fletcher PC, Crippa JA, Giampietro V, Mechelli A, Atakan Z, McGuire P. Modulation of mediotemporal and ventrostriatal function in humans by Delta9-tetrahydrocannabinol: a neural basis for the effects of Cannabis sativa on learning and psychosis. Archives of General Psychiatry. 66: 442-51. PMID 19349314 DOI: 10.1001/Archgenpsychiatry.2009.17  0.45
2009 Fusar-Poli P, Placentino A, Carletti F, Allen P, Landi P, Abbamonte M, Barale F, Perez J, McGuire P, Politi PL. Laterality effect on emotional faces processing: ALE meta-analysis of evidence Neuroscience Letters. 452: 262-267. PMID 19348735 DOI: 10.1016/J.Neulet.2009.01.065  0.427
2009 Mechelli A, Tognin S, McGuire PK, Prata D, Sartori G, Fusar-Poli P, De Brito S, Hariri AR, Viding E. Genetic vulnerability to affective psychopathology in childhood: a combined voxel-based morphometry and functional magnetic resonance imaging study. Biological Psychiatry. 66: 231-7. PMID 19278671 DOI: 10.1016/J.Biopsych.2009.01.033  0.44
2009 Fusar-Poli P, Meneghelli A, Valmaggia L, Allen P, Galvan F, McGuire P, Cocchi A. Duration of untreated prodromal symptoms and 12-month functional outcome of individuals at risk of psychosis British Journal of Psychiatry. 194: 181-182. PMID 19182184 DOI: 10.1192/Bjp.Bp.107.047951  0.514
2009 Fusar-Poli P, Crippa JA, Bhattacharyya S, Borgwardt SJ, Allen P, Martin-Santos R, Seal M, Surguladze SA, O'Carrol C, Atakan Z, Zuardi AW, McGuire PK. Distinct effects of {delta}9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing. Archives of General Psychiatry. 66: 95-105. PMID 19124693 DOI: 10.1001/Archgenpsychiatry.2008.519  0.626
2009 Broome MR, Matthiasson P, Fusar-Poli P, Woolley JB, Johns LC, Tabraham P, Bramon E, Valmaggia L, Williams SC, Brammer MJ, Chitnis X, McGuire PK. Neural correlates of executive function and working memory in the 'at-risk mental state'. The British Journal of Psychiatry : the Journal of Mental Science. 194: 25-33. PMID 19118321 DOI: 10.1192/Bjp.Bp.107.046789  0.503
2009 Fusar-Poli P, Howes O, Valli I, Allen P, Broome M, Grasby P, McGuire P. Multimodal functional imaging investigation before and after the onset of psychosis. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 12: 579-81. PMID 18925982 DOI: 10.1017/S146114570800953X  0.467
2009 Howes O, Fusar-Poli P, Allen P, Murray R, Grasby P, McGuire P. P.3.a.032 The relationship between striatal dopamine function and frontal cortical function in the aetiology of psychosis European Neuropsychopharmacology. 19. DOI: 10.1016/S0924-977X(09)70787-4  0.412
2009 Bhattacharyya S, Fusar-Poli P, Borgwardt S, Martin-Santos R, O'Carroll C, Crippa J, Atakan Z, McGuire P. P.3.02 Opposite neural effects of the main psychoactive ingredients of cannabis —implications for therapeutics European Neuropsychopharmacology. 19: S63-S64. DOI: 10.1016/S0924-977X(09)70072-0  0.396
2009 Bhattacharyya S, Fusar-Poli P, Borgwardt S, Martin-Santos R, Carroll C, Seal M, Crippa J, Atakan Z, Mcguire P. P02-01 Opposite neural effects of the main psychoactive ingredients of cannabis- neural basis for potential therapeutic effects of Cannabidiol European Psychiatry. 24: 1-1. DOI: 10.1016/S0924-9338(09)70924-1  0.314
2008 Fusar-Poli P, Allen P, McGuire P. Egas Moniz (1875-1955), the father of psychosurgery The British Journal of Psychiatry : the Journal of Mental Science. 193: 50. PMID 18700218 DOI: 10.1192/Bjp.193.1.50  0.367
2008 Fusar-Poli P, Howes O, Valmaggia L, McGuire P. 'Truman' signs and vulnerability to psychosis. The British Journal of Psychiatry : the Journal of Mental Science. 193: 168. PMID 18670010 DOI: 10.1192/Bjp.193.2.168  0.538
2008 Borgwardt SJ, Allen P, Bhattacharyya S, Fusar-Poli P, Crippa JA, Seal ML, Fraccaro V, Atakan Z, Martin-Santos R, O'Carroll C, Rubia K, McGuire PK. Neural basis of Delta-9-tetrahydrocannabinol and cannabidiol: effects during response inhibition. Biological Psychiatry. 64: 966-73. PMID 18589404 DOI: 10.1016/J.Biopsych.2008.05.011  0.443
2008 Fusar-Poli P, Borgwardt S, Valmaggia L. Heterogeneity in the assessment of the at-risk mental state for psychosis Psychiatric Services. 59: 813. PMID 18587004 DOI: 10.1176/Appi.Ps.59.7.813  0.369
2008 Fusar-Poli P, Allen P, McGuire P. Neuroimaging studies of the early stages of psychosis: A critical review European Psychiatry. 23: 237-244. PMID 18541417 DOI: 10.1016/J.Eurpsy.2008.03.008  0.442
2008 Fusar-Poli P, Abbamonte M, Borgwardt S. Differential diagnosis between the early onset of schizophrenia and bipolar disorder: potential role of neuroimaging. Cns Spectrums. 13: 363-364. PMID 18496474 DOI: 10.1017/S1092852900016503  0.33
2008 Fusar-Poli P, Klersy C, Stramesi F, Callegari A, Arbustini E, Politi P. Determinants of quality of life in Marfan syndrome. Psychosomatics. 49: 243-248. PMID 18448780 DOI: 10.1176/Appi.Psy.49.3.243  0.301
2008 Borgwardt SJ, Fusar-Poli P, Radue E, Riecher-Rössler A. Insular pathology in the at-risk mental state. European Archives of Psychiatry and Clinical Neuroscience. 258: 254-255. PMID 18327661 DOI: 10.1007/S00406-007-0794-3  0.348
2008 McGuire P, Howes OD, Stone J, Fusar-Poli P. Functional neuroimaging in schizophrenia: diagnosis and drug discovery Trends in Pharmacological Sciences. 29: 91-98. PMID 18187211 DOI: 10.1016/J.Tips.2007.11.005  0.466
2008 Borgwardt SJ, McGuire PK, Fusar-Poli P, Radue E, Riecher-Rössler A. Anterior cingulate pathology in the prodromal stage of schizophrenia. Neuroimage. 39: 553-554. PMID 17936019 DOI: 10.1016/J.Neuroimage.2007.08.047  0.435
2008 Bhattacharyya S, Fusar-Poli P, Borgwardt S, Martin-Santos R, O'Carroll C, Seal M, Crippa J, Atakan Z, McGuire P. P.1.e.020 Effects of cannabis ingredients in the temporal cortex – neural basis for potential antipsychotic effect of cannabidiol European Neuropsychopharmacology. 18: S270-S271. DOI: 10.1016/S0924-977X(08)70353-5  0.417
2008 Bhattacharyya S, Fusar-Poli P, Borgwardt S, Allen P, Martin-Santos R, O'Carroll C, Seal M, Atakan Z, McGuire P. P.3.21 Delta-9-tetrahydrocannabinol modulates activity in parahippocampal cortex and ventral striatum during memory processing European Neuropsychopharmacology. 18: s80. DOI: 10.1016/S0924-977X(08)70092-0  0.384
2008 Bhattacharyya S, Fusar-Poli P, Borgwardt S, Allen P, Martin-Santos R, O'Carroll C, Seal M, Crippa J, Atakan Z, McGuire P. DELTA-9-TETRAHYDROCANNABINOL MODULATES MEDIAL TEMP AND STRIATAL FUNCTION IN HUMANS: A NEURAL BASIS FOR THE EFFECTS OF CANNABIS ON MEMORY AND PSYCHOSIS Schizophrenia Research. 102: 245. DOI: 10.1016/S0920-9964(08)70739-4  0.397
2008 Fusar-Poli P. DOPAMINERGIC MODULATION OF PREFRONTAL FUNCTIONING IN SUBJECTS AT CLINICAL RISK FOR PSYCHOSIS: A COMBINED PET-fMRI STUDY Schizophrenia Research. 102: 30. DOI: 10.1016/S0920-9964(08)70095-1  0.372
2008 Allen P, Seal M, Valli I, Day F, Fusar-Poli P, McGuire P. Neural Correlates Of Verbal Episodic Memory In The At Risk Mental State Schizophrenia Research. 102: 29-30. DOI: 10.1016/S0920-9964(08)70093-8  0.455
2007 Fusar-Poli P, Valmaggia L, McGuire P. Can antidepressants prevent psychosis? Lancet (London, England). 370: 1746-8. PMID 18037073 DOI: 10.1016/S0140-6736(07)61732-2  0.441
2007 Fusar-Poli P, Allen P, Lee F, Surguladze S, Tunstall N, Fu CH, Brammer MJ, Cleare AJ, McGuire PK. Modulation of neural response to happy and sad faces by acute tryptophan depletion. Psychopharmacology. 193: 31-44. PMID 17375288 DOI: 10.1007/S00213-007-0757-4  0.635
2007 Fusar-Poli P, Broome MR, Matthiasson P, Williams SC, Brammer M, McGuire PK. Effects of acute antipsychotic treatment on brain activation in first episode psychosis: an fMRI study. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 17: 492-500. PMID 17337340 DOI: 10.1016/J.Euroneuro.2007.01.003  0.453
2007 Yildiz M, Borgwardt SJ, Fusar-Poli P. Is a DNA sequence variation of the gene protocadherin Y a possible explanation for the sixfold higher risk to develop schizophrenia in Moroccan males Medical Hypotheses. 69: 694. PMID 17335989 DOI: 10.1016/J.Mehy.2007.01.026  0.367
2007 Fusar-Poli P, Borgwardt S. Integrating the negative psychotic symptoms in the high risk criteria for the prediction of psychosis Medical Hypotheses. 69: 959-960. PMID 17335988 DOI: 10.1016/J.Mehy.2006.12.044  0.369
2007 O'Connor R, Sota M, Cortesi M, Fusar-Poli P. Quetiapine as a first-choice agent in subjects at high-risk to psychosis? Medical Hypotheses. 69: 230. PMID 17258403 DOI: 10.1016/J.Mehy.2006.11.037  0.358
2007 Fusar-Poli P, Perez J, Broome M, Borgwardt S, Placentino A, Caverzasi E, Cortesi M, Veggiotti P, Politi P, Barale F, McGuire P. Neurofunctional correlates of vulnerability to psychosis: a systematic review and meta-analysis. Neuroscience and Biobehavioral Reviews. 31: 465-84. PMID 17223194 DOI: 10.1016/J.Neubiorev.2006.11.006  0.539
2007 Fusar-Poli P, Caverzasi E, Cortesi M. Pooling of data in psychiatric neuroimaging: A bridge towards clinical neuroimaging? European Psychiatry. 22: 265. PMID 17142015 DOI: 10.1016/J.Eurpsy.2006.08.006  0.318
2007 Bhattacharyya S, Fusar-Poli P, Borgwardt S, Allen P, Martin-Santos R, O'Carroll C, Seal M, Atakan Z, Nosarti C, McGuire P. P.1.e.008 Delta-9-tetrahydrocannabinol modulates activity in temporal cortex during processing of verbal episodic memory European Neuropsychopharmacology. 17: S285. DOI: 10.1016/S0924-977X(07)70398-X  0.389
2007 Fusar-Poli P, Broome M, Matthiasson P, Woolley J, Johns L, Tabraham P, Bramon E, Valmaggia L, Williams S, Brammer S, Chitnis X, McGuire P. Paired associate learning in subjects at risk for psychosis: fMRI study European Psychiatry. 22: S314. DOI: 10.1016/J.Eurpsy.2007.01.1044  0.462
2006 Fusar-Poli P, Broome MR. Conceptual issues in psychiatric neuroimaging. Current Opinion in Psychiatry. 19: 608-612. PMID 17012940 DOI: 10.1097/01.Yco.0000245750.98749.1B  0.32
2006 Fusar-Poli P, Allen P, McGuire P, Placentino A, Cortesi M, Perez J. Neuroimaging and electrophysiological studies of the effects of acute tryptophan depletion: a systematic review of the literature. Psychopharmacology. 188: 131-43. PMID 16915379 DOI: 10.1007/S00213-006-0493-1  0.408
2006 Allen PP, Cleare AJ, Lee F, Fusar-Poli P, Tunstall N, Fu CH, Brammer MJ, McGuire PK. Effect of acute tryptophan depletion on pre-frontal engagement. Psychopharmacology. 187: 486-97. PMID 16823591 DOI: 10.1007/S00213-006-0444-X  0.425
2006 Fusar-Poli P, Broome M, Matthiasson P, Woolley J, Valmaggia L, Tabraham P, Johns L, Bramon E, Williams S, Brammer M, McGuire P. P.3.d.013 Correlation between acute atypical antipsychotic treatment and cognitive functioning in first episode psychosis European Neuropsychopharmacology. 16: S436. DOI: 10.1016/S0924-977X(06)70560-0  0.427
2006 Broome M, Matthiasson P, Fusar-Poli P, Woolley J, Johns L, Tabraham P, Bramon E, Valmaggia L, Williams S, Brammer M, Chitnis X, McGuire P. WC4C NEURAL CORRELATES OF EXECUTIVE FUNCTION AND WORKING MEMORY IN THE ‘AT-RISK MENTAL STATE’ Schizophrenia Research. 86: S10. DOI: 10.1016/S0920-9964(06)70031-7  0.451
Show low-probability matches.